I
106TH CONGRESS
2D SESSION
H. R. 4680
To amend title XVIII of the Social Security Act to provide for a voluntary
program for prescription drug coverage under the Medicare Program,
to modernize the Medicare Program, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
JUNE 15, 2000
Mr. THOMAS (for himself, Mr. BURR of North Carolina, Mr. PETERSON of
Minnesota, Mr. BLILEY, and Mr. HALL of Texas) introduced the fol-
lowing bill; which was referred to the Committee on Ways and Means,
and in addition to the Committee on Commerce, for a period to be subse-
quently determined by the Speaker, in each case for consideration of such
provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to provide
for a voluntary program for prescription drug coverage
under the Medicare Program, to modernize the Medicare
Program, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) SHORT TITLE.—This Act may be cited as the
‘‘Medicare Rx 2000 Act’’.
(b) TABLE OF CONTENTS.—The table of contents of
this Act is as follows:
Sec. 1. Short title; table of contents.
TITLE I—MEDICARE PRESCRIPTION DRUG BENEFIT
Sec. 101. Establishment of a medicare prescription drug benefit.
‘‘PART D—VOLUNTARY PRESCRIPTION DRUG BENEFIT PROGRAM
‘‘Sec. 1860A. Benefits; eligibility; enrollment; and coverage period.
‘‘Sec. 1860B. Requirements for qualified prescription drug coverage.
‘‘Sec. 1860C. Beneficiary protections for qualified prescription drug cov-
erage.
‘‘Sec. 1860D. Requirements for prescription drug plan (PDP) sponsors.
‘‘Sec. 1860E. Process for beneficiaries to select qualified prescription drug
coverage.
‘‘Sec. 1860F. Premiums.
‘‘Sec. 1860G. Premium and cost-sharing subsidies for low-income individ-
uals.
‘‘Sec. 1860H. Subsidies for all medicare beneficiaries through reinsurance
for qualified prescription drug coverage.
‘‘Sec. 1860I. Medicare Prescription Drug Account in Federal Supple-
mentary Medical Insurance Trust Fund.
‘‘Sec. 1860J. Definitions; treatment of references to provisions in part C.
Sec. 102. Offering of qualified prescription drug coverage under the
Medicare+Choice program.
Sec. 103. Medicaid amendments.
Sec. 104. Medigap transition provisions.
TITLE II—MODERNIZATION OF ADMINISTRATION OF MEDICARE
Subtitle A—Medicare Benefits Administration
Sec. 201. Establishment of administration.
‘‘Sec. 1807. Medicare Benefits Administration.
Sec. 202. Miscellaneous administrative provisions.
Subtitle B—Oversight of Financial Sustainability of the Medicare Program
Sec. 211. Additional requirements for annual financial report and oversight on
medicare program.
Subtitle C—Changes in Medicare Coverage and Appeals Process
Sec. 221. Revisions to medicare appeals process.
Sec. 222. Provisions with respect to limitations on liability of beneficiaries.
Sec. 223. Waivers of liability for cost sharing amounts.
Sec. 224. Elimination of motions by the Secretary on decisions of the Provider
Reimbursement Review Board.
TITLE III—MEDICARE+CHOICE REFORMS; PRESERVATION OF
MEDICARE PART B DRUG BENEFIT
Subtitle A—Medicare+Choice Reforms
Sec. 301. Increase in national per capita Medicare+Choice growth percentage
in 2001 and 2002.
Sec. 302. Permanently removing application of budget neutrality beginning in
2002.
Sec. 303. Increasing minimum payment amount.
Sec. 304. Allowing movement to 50:50 percent blend in 2002.
Sec. 305. Increased update for payment areas with only one or no
Medicare+Choice contracts.
Sec. 306. Permitting higher negotiated rates in certain Medicare+Choice pay-
ment areas below national average.
Sec. 307. 10-year phase in of risk adjustment based on data from all settings.
Subtitle B—Preservation of Medicare Coverage of Drugs and Biologicals
Sec. 311. Preservation of coverage of drugs and biologicals under part B of the
medicare program.
TITLE I—MEDICARE
PRESCRIPTION DRUG BENEFIT
SEC. 101. ESTABLISHMENT OF A MEDICARE PRESCRIPTION
DRUG BENEFIT.
(a) IN GENERAL.—Title XVIII of the Social Security
Act is amended—
(1) by redesignating part D as part E; and
(2) by inserting after part C the following new
part:
‘‘PART D—VOLUNTARY PRESCRIPTION DRUG BENEFIT
PROGRAM
‘‘SEC. 1860A. BENEFITS; ELIGIBILITY; ENROLLMENT; AND
COVERAGE PERIOD.
‘‘(a) PROVISION OF QUALIFIED PRESCRIPTION DRUG
COVERAGE THROUGH ENROLLMENT IN PLANS.—Subject
to the succeeding provisions of this part, each individual
who is enrolled under part B is entitled to obtain qualified
prescription 
drug 
coverage 
(described 
in 
section
1860B(a)) as follows:
‘‘(1) MEDICARE+CHOICE
PLAN.—If the indi-
vidual is eligible to enroll in a Medicare+Choice plan
that provides qualified prescription drug coverage
under section 1851(j), the individual may enroll in
the plan and obtain coverage through such plan.
‘‘(2) PRESCRIPTION DRUG PLAN.—If the indi-
vidual is not enrolled in a Medicare+Choice plan
that provides qualified prescription drug coverage,
the individual may enroll under this part in a pre-
scription drug plan (as defined in section 1860C(a)).
Such individuals shall have a choice of such plans under
section 1860E(d).
‘‘(b) GENERAL ELECTION PROCEDURES.—
‘‘(1) IN GENERAL.—An individual may elect to
enroll in a prescription drug plan under this part, or
elect the option of qualified prescription drug cov-
erage under a Medicare+Choice plan under part C,
and change such election only in such manner and
form as may be prescribed by regulations of the Ad-
ministrator of the Medicare Benefits Administration
(appointed under section 1807(b)) (in this part re-
ferred to as the ‘Medicare Benefits Administrator’)
and only during an election period prescribed in or
under this subsection.
‘‘(2) ELECTION PERIODS.—
‘‘(A) IN GENERAL.—Except as provided in
this paragraph, the election periods under this
subsection shall be the same as the coverage
election periods under the Medicare+Choice
program under section 1851(e), including—
‘‘(i) annual coordinated election peri-
ods; and
‘‘(ii) special election periods.
In applying the last sentence of section
1851(e)(4) (relating to discontinuance of a
Medicare+Choice election during the first year
of eligibility) under this subparagraph, in the
case of an election described in such section in
which the individual had elected or is provided
qualified prescription drug coverage at the time
of such first enrollment, the individual shall be
permitted to enroll in a prescription drug plan
under this part at the time of the election of
coverage under the original fee-for-service plan.
‘‘(B) INITIAL ELECTION PERIODS.—
‘‘(i) INDIVIDUALS
CURRENTLY
COV-
ERED.—In the case of an individual who is
enrolled under part B as of November 1,
2002, there shall be an initial election pe-
riod of 6 months beginning on that date.
‘‘(ii) INDIVIDUAL
COVERED
IN
FU-
TURE.—In the case of an individual who is
first enrolled under part B after November
1, 2002, there shall be an initial election
period which is the same as the initial elec-
tion period under section 1851(e)(1).
‘‘(C) ADDITIONAL SPECIAL ELECTION PE-
RIODS.—The Medicare Benefits Administrator
shall establish special election periods—
‘‘(i) in cases of individuals who have
and involuntarily lose prescription drug
coverage described in subsection (c)(2)(C);
and
‘‘(ii) in cases described in section
1837(h) (relating to errors in enrollment),
in the same manner as such section applies
to part B.
‘‘(D) ONE-TIME ENROLLMENT PERMITTED
FOR CURRENT PART A ONLY BENEFICIARIES.—
In the case of an individual who as of Novem-
ber 1, 2002—
‘‘(i) is entitled to benefits under part
A; and
‘‘(ii) is not (and has not previously
been) enrolled under part B;
the individual shall be eligible to enroll in a pre-
scription drug plan under this part but only
during the period described in subparagraph
(B)(i). If the individual enrolls in such a plan,
the individual may change such enrollment
under this part, but the individual may not en-
roll in a Medicare+Choice plan under part C
unless the individual enrolls under part B.
Nothing in this subparagraph shall be con-
strued as providing for coverage under a pre-
scription drug plan of benefits that are excluded
because 
of 
the 
application 
of 
section
1860B(f)(2)(B).
‘‘(c) GUARANTEED ISSUE; COMMUNITY RATING; AND
NONDISCRIMINATION.—
‘‘(1) GUARANTEED ISSUE.—
‘‘(A) IN GENERAL.—An eligible individual
who is eligible to elect qualified prescription
drug coverage under a prescription drug plan or
Medicare+Choice plan at a time during which
elections are accepted under this part with re-
spect to the plan shall not be denied enrollment
based on any health status-related factor (de-
scribed in section 2702(a)(1) of the Public
Health Service Act) or any other factor.
‘‘(B) 
MEDICARE+CHOICE
LIMITATIONS
PERMITTED.—The provisions of paragraphs (2)
and (3) (other than subparagraph (C)(i), relat-
ing to default enrollment) of section 1851(g)
(relating to priority and limitation on termi-
nation of election) shall apply to PDP sponsors
under this subsection.
‘‘(2) COMMUNITY-RATED PREMIUM.—
‘‘(A) IN GENERAL.—In the case of an indi-
vidual who maintains (as determined under sub-
paragraph (C)) continuous prescription drug
coverage since first qualifying to elect prescrip-
tion drug coverage under this part, a PDP
sponsor or Medicare+Choice organization offer-
ing 
a 
prescription 
drug 
plan 
or
Medicare+Choice plan that provides qualified
prescription drug coverage and in which the in-
dividual is enrolled may not deny, limit, or con-
dition the coverage or provision of covered pre-
scription drug benefits or increase the premium
under the plan based on any health status-re-
lated factor described in section 2702(a)(1) of
the Public Health Service Act or any other fac-
tor.
‘‘(B) LATE
ENROLLMENT
PENALTY.—In
the case of an individual who does not maintain
such continuous prescription drug coverage, a
PDP sponsor or Medicare+Choice organization
may (notwithstanding any provision in this
title) increase the premium otherwise applicable
or impose a pre-existing condition exclusion
with respect to qualified prescription drug cov-
erage in a manner that reflects additional actu-
arial risk involved. Such a risk shall be estab-
lished through an appropriate actuarial opinion
of the type described in subparagraphs (A)
through (C) of section 2103(c)(4).
‘‘(C) CONTINUOUS
PRESCRIPTION
DRUG
COVERAGE.—An individual is considered for
purposes of this part to be maintaining contin-
uous prescription drug coverage on and after a
date if the individual establishes that there is
no period of 63 days or longer on and after
such date (beginning not earlier than January
1, 2003) during all of which the individual did
not have any of the following prescription drug
coverage:
‘‘(i) COVERAGE UNDER PRESCRIPTION
DRUG
PLAN
OR
MEDICARE+CHOICE
PLAN.—Qualified prescription drug cov-
erage under a prescription drug plan or
under a Medicare+Choice plan.
‘‘(ii) MEDICAID PRESCRIPTION DRUG
COVERAGE.—Prescription drug coverage
under a medicaid plan under title XIX, in-
cluding through the Program of All-inclu-
sive Care for the Elderly (PACE) under
section 1934, through a social health main-
tenance organization (referred to in section
4104(c) of the Balanced Budget Act of
1997), or through a Medicare+Choice
project that demonstrates the application
of capitation payment rates for frail elderly
medicare beneficiaries through the use of a
interdisciplinary team and through the
provision of primary care services to such
beneficiaries by means of such a team at
the nursing facility involved.
‘‘(iii) PRESCRIPTION DRUG COVERAGE
UNDER GROUP HEALTH PLAN.—Any out-
patient prescription drug coverage under a
group health plan, including a health bene-
fits plan under the Federal Employees
Health Benefit Plan under chapter 89 of
title 5, United States Code, and a qualified
retiree prescription drug plan as defined in
section 1860H(f)(1).
‘‘(iv) PRESCRIPTION DRUG COVERAGE
UNDER
CERTAIN
MEDIGAP
POLICIES.—
Coverage under a medicare supplemental
policy under section 1882 that provides
benefits for prescription drugs (whether or
not such coverage conforms to the stand-
ards for packages of benefits under section
1882(p)(1)), but only if the policy was in
effect on January 1, 2003, and only until
the date such coverage is terminated.
‘‘(v) STATE PHARMACEUTICAL ASSIST-
ANCE PROGRAM.—Coverage of prescription
drugs under a State pharmaceutical assist-
ance program.
‘‘(vi) VETERANS’ COVERAGE OF PRE-
SCRIPTION DRUGS.—Coverage of prescrip-
tion drugs for veterans under chapter 17
of title 38, United States Code.
‘‘(D) CERTIFICATION.—For purposes of
carrying out this paragraph, the certifications
of the type described in sections 2701(e) of the
Public Health Service Act and in section
9801(e) of the Internal Revenue Code shall also
include a statement for the period of coverage
of whether the individual involved had prescrip-
tion drug coverage described in subparagraph
(C).
‘‘(E) CONSTRUCTION.—Nothing in this
section shall be construed as preventing the
disenrollment of an individual from a prescrip-
tion drug plan or a Medicare+Choice plan
based on the termination of an election de-
scribed in section 1851(g)(3), including for non-
payment of premiums or for other reasons spec-
ified in subsection (d)(3), which takes into ac-
count a grace period described in section
1851(g)(3)(B)(i).
‘‘(3) NONDISCRIMINATION.—A PDP sponsor of-
fering a prescription drug plan shall not establish a
service area in a manner that would discriminate
based on health or economic status of potential en-
rollees.
‘‘(d) EFFECTIVE DATE OF ELECTIONS.—
‘‘(1) IN GENERAL.—Except as provided in this
section, the Medicare Benefits Administrator shall
provide that elections under subsection (b) take ef-
fect at the same time as the Secretary provides that
similar elections under section 1851(e) take effect
under section 1851(f).
‘‘(2) NO ELECTION EFFECTIVE BEFORE 2003.—
In no case shall any election take effect before Janu-
ary 1, 2003.
‘‘(3) TERMINATION.—The Medicare Benefits
Administrator shall provide for the termination of
elections in the case of—
‘‘(A) termination of coverage under part B
(other than the case of an individual described
in subsection (b)(2)(D) (relating to part A only
individuals); and
‘‘(B) termination of elections described in
section 1851(g)(3) (including failure to pay re-
quired premiums).
‘‘SEC. 1860B. REQUIREMENTS FOR QUALIFIED PRESCRIP-
TION DRUG COVERAGE.
‘‘(a) REQUIREMENTS.—
‘‘(1) IN GENERAL.—For purposes of this part
and part C, the term ‘qualified prescription drug
coverage’ means either of the following:
‘‘(A) STANDARD COVERAGE WITH ACCESS
TO
NEGOTIATED
PRICES.—Standard coverage
(as defined in subsection (b)) and access to ne-
gotiated prices under subsection (d).
‘‘(B) ACTUARIALLY
EQUIVALENT
COV-
ERAGE
WITH
ACCESS
TO
NEGOTIATED
PRICES.—Coverage of covered outpatient drugs
which meets the alternative coverage require-
ments of subsection (c) and access to negotiated
prices under subsection (d).
‘‘(2) PERMITTING
ADDITIONAL
OUTPATIENT
PRESCRIPTION DRUG COVERAGE.—
‘‘(A) IN
GENERAL.—Subject to subpara-
graph (B), nothing in this part shall be con-
strued as preventing qualified prescription drug
coverage from including coverage of covered
outpatient drugs that exceeds the coverage re-
quired under paragraph (1), but any such addi-
tional coverage shall be limited to coverage of
covered outpatient drugs.
‘‘(B) 
DISAPPROVAL
AUTHORITY.—The
Medicare Benefits Administrator shall review
the offering of qualified prescription drug cov-
erage under this part or part C. If the Adminis-
trator finds that, in the case of a qualified pre-
scription drug coverage under a prescription
drug plan or a Medicare+Choice plan, that the
organization or sponsor offering the coverage is
purposefully engaged in activities intended to
result in favorable selection of those eligible
medicare 
beneficiaries 
obtaining 
coverage
through the plan, the Administrator may termi-
nate the contract with the sponsor or organiza-
tion under this part or part C.
‘‘(3) APPLICATION OF SECONDARY PAYOR PRO-
VISIONS.—The provisions of section 1852(a)(4) shall
apply under this part in the same manner as they
apply under part C.
‘‘(b) STANDARD COVERAGE.—For purposes of this
part, the ‘standard coverage’ is coverage of covered out-
patient drugs (as defined in subsection (f)) that meets the
following requirements:
‘‘(1) DEDUCTIBLE.—The coverage has an an-
nual deductible—
‘‘(A) for 2003, that is equal to $250; or
‘‘(B) for a subsequent year, that is equal
to the amount specified under this paragraph
for the previous year increased by the percent-
age specified in paragraph (5) for the year in-
volved.
Any amount determined under subparagraph (B)
that is not a multiple of $5 shall be rounded to the
nearest multiple of $5.
‘‘(2) LIMITS ON COST-SHARING.—The coverage
has cost-sharing (for costs above the annual deduct-
ible specified in paragraph (1) and up to the initial
coverage limit under paragraph (3)) that is equal to
50 percent or that is actuarially consistent (using
processes established under subsection (e)) with an
average expected payment of 50 percent of such
costs.
‘‘(3) INITIAL
COVERAGE
LIMIT.—Subject to
paragraph (4), the coverage has an initial coverage
limit on the maximum costs that may be recognized
for payment purposes (above the annual deduct-
ible)—
‘‘(A) for 2003, that is equal to $2,100; or
‘‘(B) for a subsequent year, that is equal
to the amount specified in this paragraph for
the previous year, increased by the annual per-
centage increase described in paragraph (5) for
the year involved.
Any amount determined under subparagraph (B)
that is not a multiple of $25 shall be rounded to the
nearest multiple of $25.
‘‘(4) LIMITATION ON OUT-OF-POCKET EXPENDI-
TURES BY BENEFICIARY.—
‘‘(A) IN GENERAL.—Notwithstanding para-
graph (3), the coverage provides benefits with-
out any cost-sharing after the individual has in-
curred costs (as described in subparagraph (C))
for covered outpatient drugs in a year equal to
the annual out-of-pocket limit specified in sub-
paragraph (B).
‘‘(B) ANNUAL
OUT-OF-POCKET
LIMIT.—
For purposes of this part, the ‘annual out-of-
pocket limit’ specified in this subparagraph—
‘‘(i) for 2003, is equal to $6,000; or
‘‘(ii) for a subsequent year, is equal to
the amount specified in the subparagraph
for the previous year, increased by the an-
nual percentage increase described in para-
graph (5) for the year involved.
Any amount determined under clause (ii) that
is not a multiple of $100 shall be rounded to
the nearest multiple of $100.
‘‘(C) APPLICATION.—In applying subpara-
graph (A)—
‘‘(i) incurred costs shall only include
costs incurred for the annual deductible
(described in paragraph (1)), cost-sharing
(described in paragraph (2)), and amounts
for which benefits are not provided because
of the application of the initial coverage
limit described in paragraph (3); but
‘‘(ii) costs shall be treated as incurred
without regard to whether the individual or
another person, including a State program,
has paid for such costs, but shall not be
counted insofar as such costs are covered
as benefits under a prescription drug plan,
a Medicare+Choice plan, or other third-
party coverage.
‘‘(5) ANNUAL
PERCENTAGE
INCREASE.—For
purposes of this part, the annual percentage increase
specified in this paragraph for a year is equal to the
annual percentage increase in average per capita ag-
gregate expenditures for covered outpatient drugs in
the United States for medicare beneficiaries, as de-
termined by the Medicare Benefits Administrator for
the 12-month period ending in July of the previous
year.
‘‘(c) ALTERNATIVE COVERAGE REQUIREMENTS.—A
prescription drug plan or Medicare+Choice plan may pro-
vide a different prescription drug benefit design from the
standard coverage described in subsection (b)(1) so long
as the following requirements are met:
‘‘(1) ASSURING AT LEAST ACTUARIALLY EQUIV-
ALENT COVERAGE.—
‘‘(A) ASSURING
EQUIVALENT
VALUE
OF
TOTAL COVERAGE.—The actuarial value of the
total coverage (as determined under subsection
(e)) is at least equal to the actuarial value (as
so determined) of standard coverage.
‘‘(B) 
ASSURING
EQUIVALENT
UNSUB-
SIDIZED
VALUE
OF
COVERAGE.—The unsub-
sidized value of the coverage is at least equal to
the unsubsidized value of standard coverage.
For purposes of this subparagraph, the unsub-
sidized value of coverage is the amount by
which the actuarial value of the coverage (as
determined under subsection (e)) exceeds the
actuarial value of the reinsurance subsidy pay-
ments under section 1860H with respect to
such coverage.
‘‘(C) ASSURING STANDARD PAYMENT FOR
COSTS AT INITIAL COVERAGE LIMIT.—The cov-
erage is designed, based upon an actuarially
representative pattern of utilization (as deter-
mined under subsection (e)), to provide for the
payment, with respect to costs incurred that are
equal to the sum of the deductible under sub-
section (b)(1) and the initial coverage limit
under subsection (b)(3), of an amount equal to
at least such initial coverage limit multiplied by
the percentage specified in subsection (b)(2).
‘‘(2) LIMITATION ON OUT-OF-POCKET EXPENDI-
TURES BY BENEFICIARIES.—The coverage provides
the limitation on out-of-pocket expenditures by bene-
ficiaries described in subsection (b)(4).
‘‘(d) ACCESS
TO
NEGOTIATED
PRICES.—Under
qualified prescription drug coverage offered by a PDP
sponsor or a Medicare+Choice organization, the sponsor
or organization shall provide beneficiaries with access to
negotiated prices (including applicable discounts) used for
payment for covered outpatient drugs, regardless of the
fact that no benefits may be payable under the coverage
with respect to such drugs because of the application of
cost-sharing or an initial coverage limit (described in sub-
section (b)(3)).
‘‘(e) ACTUARIAL VALUATION; DETERMINATION OF
ANNUAL PERCENTAGE INCREASES.—
‘‘(1) PROCESSES.—For purposes of this section,
the Medicare Benefits Administrator shall establish
processes and methods—
‘‘(A) for determining the actuarial valu-
ation of prescription drug coverage, including—
‘‘(i) an actuarial valuation of standard
coverage and of the reinsurance subsidy
payments under section 1860H;
‘‘(ii) the use of generally accepted ac-
tuarial principles and methodologies; and
‘‘(iii) applying the same methodology
for determinations of alternative coverage
under subsection (c) as is used with re-
spect to determinations of standard cov-
erage under subsection (b); and
‘‘(B) for determining annual percentage in-
creases described in subsection (b)(5).
‘‘(2) USE OF OUTSIDE ACTUARIES.—Under the
processes under paragraph (1)(A), PDP sponsors
and Medicare+Choice organizations may use actu-
arial opinions certified by independent, qualified ac-
tuaries to establish actuarial values.
‘‘(f) COVERED OUTPATIENT DRUGS DEFINED.—
‘‘(1) IN GENERAL.—Except as provided in this
subsection, for purposes of this part, the term ‘cov-
ered outpatient drug’ means—
‘‘(A) a drug that may be dispensed only
upon a prescription and that is described in
subparagraph (A)(i) or (A)(ii) of section
1927(k)(2); or
‘‘(B) a biological product or insulin de-
scribed in subparagraph (B) or (C) of such sec-
tion.
‘‘(2) EXCLUSIONS.—
‘‘(A) IN GENERAL.—Such term does not
include drugs or classes of drugs, or their med-
ical uses, which may be excluded from coverage
or 
otherwise 
restricted 
under 
section
1927(d)(2), other than subparagraph (E) there-
of (relating to smoking cessation agents).
‘‘(B) AVOIDANCE
OF
DUPLICATE
COV-
ERAGE.—A drug prescribed for an individual
that would otherwise be a covered outpatient
drug under this part shall not be so considered
if payment for such drug is available under part
A or B (but shall be so considered if such pay-
ment is not available because benefits under
part A or B have been exhausted), without re-
gard to whether the individual is entitled to
benefits under part A or enrolled under part B.
‘‘(3) APPLICATION
OF
FORMULARY
RESTRIC-
TIONS.—A drug prescribed for an individual that
would otherwise be a covered outpatient drug under
this part shall not be so considered under a plan if
the plan excludes the drug under a formulary that
meets the requirements of section 1860C(f)(2) (in-
cluding providing an appeal process).
‘‘(4) APPLICATION
OF
GENERAL
EXCLUSION
PROVISIONS.—A 
prescription 
drug 
plan 
or
Medicare+Choice plan may exclude from qualified
prescription drug coverage any covered outpatient
drug—
‘‘(A) for which payment would not be
made if section 1862(a) applied to part D; or
‘‘(B) which are not prescribed in accord-
ance with the plan or this part.
Such exclusions are determinations subject to recon-
sideration and appeal pursuant to section 1860C(f).
‘‘SEC. 1860C. BENEFICIARY PROTECTIONS FOR QUALIFIED
PRESCRIPTION DRUG COVERAGE.
‘‘(a) GUARANTEED
ISSUE
AND
NONDISCRIMINA-
TION.—For provisions requiring guaranteed issue, com-
munity-rated premiums, and nondiscrimination, see sec-
tions 1860A(c) and 1860F(b).
‘‘(b) DISSEMINATION OF INFORMATION.—
‘‘(1) GENERAL INFORMATION.—A PDP sponsor
shall disclose, in a clear, accurate, and standardized
form to each enrollee with a prescription drug plan
offered by the sponsor under this part at the time
of enrollment and at least annually thereafter, the
information described in section 1852(c)(1) relating
to such plan. Such information includes the fol-
lowing:
‘‘(A) Access to covered outpatient drugs,
including access through pharmacy networks.
‘‘(B) How any formulary used by the spon-
sor functions.
‘‘(C) Co-payments and deductible require-
ments.
‘‘(D) Grievance and appeals procedures.
‘‘(2) DISCLOSURE UPON REQUEST OF GENERAL
COVERAGE, UTILIZATION, AND GRIEVANCE INFORMA-
TION.—Upon request of an individual eligible to en-
roll under a prescription drug plan, the PDP spon-
sor shall provide the information described in section
1852(c)(2) (other than subparagraph (D)) to such
individual.
‘‘(3) RESPONSE TO BENEFICIARY QUESTIONS.—
Each PDP sponsor offering a prescription drug plan
shall have a mechanism for providing specific infor-
mation to enrollees upon request. The sponsor shall
make available, through an Internet website and in
writing upon request, information on specific
changes in its formulary.
‘‘(4) CLAIMS INFORMATION.—Each PDP spon-
sor offering a prescription drug plan must furnish to
enrolled individuals in a form easily understandable
to such individuals an explanation of benefits (in ac-
cordance with section 1806(a) or in a comparable
manner) and a notice of the benefits in relation to
initial coverage limit and annual out-of-pocket limit
for the current year, whenever prescription drug
benefits are provided under this part (except that
such notice need not be provided more often than
monthly).
‘‘(c) ACCESS TO COVERED BENEFITS.—
‘‘(1) ASSURING PHARMACY ACCESS.—The PDP
sponsor of the prescription drug plan shall secure
the participation of sufficient numbers of pharmacies
(which may include mail order pharmacies) to en-
sure convenient access (including adequate emer-
gency access) for enrolled beneficiaries. Nothing in
this paragraph shall be construed as requiring the
participation of all pharmacies in any area under a
plan.
‘‘(2) ACCESS TO NEGOTIATED PRICES FOR PRE-
SCRIPTION DRUGS.—The PDP sponsor of a prescrip-
tion drug plan shall issue such a card that may be
used by an enrolled beneficiary to assure access to
negotiated prices under section 1860B(d) for the
purchase of prescription drugs for which coverage is
not otherwise provided under the prescription drug
plan.
‘‘(3) REQUIREMENTS
ON
DEVELOPMENT
AND
APPLICATION OF FORMULARIES.—Insofar as a PDP
sponsor of a prescription drug plan uses a for-
mulary, the following requirements must be met:
‘‘(A) FORMULARY COMMITTEE.—The spon-
sor must establish a pharmaceutical and thera-
peutic committee that develops the formulary.
Such committee shall include at least one physi-
cian and at least one pharmacist.
‘‘(B) INCLUSION OF DRUGS IN ALL THERA-
PEUTIC CATEGORIES.—The formulary must in-
clude drugs within all therapeutic categories
and classes of covered outpatient drugs (al-
though not necessarily for all drugs within such
categories and classes).
‘‘(C) APPEALS AND EXCEPTIONS TO APPLI-
CATION.—The PDP sponsor must have, as part
of the appeals process under subsection (i)(2),
a process for appeals for denials of coverage
based on such application of the formulary.
‘‘(d) COST AND UTILIZATION MANAGEMENT; QUAL-
ITY ASSURANCE; MEDICATION THERAPY MANAGEMENT
PROGRAM.—
‘‘(1) IN
GENERAL.—The PDP sponsor shall
have in place—
‘‘(A) an effective cost and drug utilization
management program, including appropriate in-
centives to use generic drugs, when appropriate;
‘‘(B) quality assurance measures and sys-
tems to reduce medical errors and adverse drug
interactions, including a medication therapy
management program described in paragraph
(2); and
‘‘(C) a program to control fraud, abuse,
and waste.
‘‘(2) MEDICATION THERAPY MANAGEMENT PRO-
GRAM.—
‘‘(A) IN GENERAL.—A medication therapy
management program described in this para-
graph is a program of drug therapy manage-
ment and medication administration that is de-
signed to assure that covered outpatient drugs
under the prescription drug plan are appro-
priately used to achieve therapeutic goals and
reduce the risk of adverse events, including ad-
verse drug interactions.
‘‘(B) ELEMENTS.—Such program may
include—
‘‘(i) 
enhanced 
beneficiary 
under-
standing of such appropriate use through
beneficiary 
education, 
counseling, 
and
other appropriate means; and
‘‘(ii) increased beneficiary adherence
with 
prescription 
medication 
regimens
through medication refill reminders, special
packaging, and other appropriate means.
‘‘(C) DEVELOPMENT OF PROGRAM IN CO-
OPERATION
WITH
LICENSED
PHARMACISTS.—
The program shall be developed in cooperation
with licensed pharmacists and physicians.
‘‘(D) 
CONSIDERATIONS
IN
PHARMACY
FEES.—The PDP sponsor of a prescription
drug program shall take into account, in estab-
lishing fees for pharmacists and others pro-
viding services under the medication therapy
management program, the resources and time
used in implementing the program.
‘‘(3) TREATMENT OF ACCREDITATION.—Section
1852(e)(4) (relating to treatment of accreditation)
shall apply to prescription drug plans under this
part with respect to the following requirements, in
the same manner as they apply to Medicare+Choice
plans under part C with respect to the requirements
described in a clause of section 1852(e)(4)(B):
‘‘(A) Paragraph (1) (including quality as-
surance), including medication therapy manage-
ment program under paragraph (2).
‘‘(B) Subsection (c)(1) (relating to access
to covered benefits).
‘‘(C) Subsection (g) (relating to confiden-
tiality and accuracy of enrollee records).
‘‘(e) GRIEVANCE MECHANISM.—Each PDP sponsor
shall provide meaningful procedures for hearing and re-
solving grievances between the organization (including any
entity or individual through which the sponsor provides
covered benefits) and enrollees with prescription drug
plans of the sponsor under this part in accordance with
section 1852(f).
‘‘(f) COVERAGE
DETERMINATIONS, RECONSIDER-
ATIONS, AND APPEALS.—
‘‘(1) IN GENERAL.—A PDP sponsor shall meet
the requirements of section 1852(g) with respect to
covered benefits under the prescription drug plan it
offers under this part in the same manner as such
requirements apply to a Medicare+Choice organiza-
tion with respect to benefits it offers under a
Medicare+Choice plan under part C.
‘‘(2) APPEALS
OF
FORMULARY
DETERMINA-
TIONS.—Under the appeals process under paragraph
(1) an individual who is enrolled in a prescription
drug plan offered by a PDP sponsor may appeal to
obtain coverage for a medically necessary covered
outpatient drug that is not on the formulary of the
sponsor (established under subsection (c)) if the pre-
scribing physician determines that the therapeuti-
cally similar drug that is on the formulary is not ef-
fective for the enrollee or has significant adverse ef-
fects for the enrollee.
‘‘(g) CONFIDENTIALITY
AND ACCURACY
OF EN-
ROLLEE RECORDS.—A PDP sponsor shall meet the re-
quirements of section 1852(h) with respect to enrollees
under this part in the same manner as such requirements
apply to a Medicare+Choice organization with respect to
enrollees under part C.
‘‘SEC. 1860D. REQUIREMENTS FOR PRESCRIPTION DRUG
PLAN (PDP) SPONSORS.
‘‘(a) GENERAL REQUIREMENTS.—Each PDP sponsor
of a prescription drug plan shall meet the following re-
quirements:
‘‘(1) LICENSURE.—Subject to subsection (c),
the sponsor is organized and licensed under State
law as a risk-bearing entity eligible to offer health
insurance or health benefits coverage in each State
in which it offers a prescription drug plan.
‘‘(2) ASSUMPTION OF FULL FINANCIAL RISK.—
‘‘(A) IN
GENERAL.—Subject to subpara-
graph (B) and section 1860E(d)(2), the entity
assumes full financial risk on a prospective
basis for qualified prescription drug coverage
that it offers under a prescription drug plan
and that is not covered under reinsurance
under section 1860H.
‘‘(B) REINSURANCE PERMITTED.—The en-
tity may obtain insurance or make other ar-
rangements for the cost of coverage provided to
any enrolled member under this part.
‘‘(3) SOLVENCY FOR UNLICENSED SPONSORS.—
In the case of a sponsor that is not described in
paragraph (1), the sponsor shall meet solvency
standards established by the Medicare Benefits Ad-
ministrator under subsection (d).
‘‘(b) CONTRACT REQUIREMENTS.—
‘‘(1) IN GENERAL.—The Medicare Benefits Ad-
ministrator shall not permit the election under sec-
tion 1860A of a prescription drug plan offered by a
PDP sponsor under this part, and the sponsor shall
not be eligible for payments under section 1860G or
1860H, unless the Administrator has entered into a
contract under this subsection with the sponsor with
respect to the offering of such plan. Such a contract
with a sponsor may cover more than 1 prescription
drug plan. Such contract shall provide that the spon-
sor agrees to comply with the applicable require-
ments and standards of this part and the terms and
conditions of payment as provided for in this part.
‘‘(2) 
INCORPORATION
OF
CERTAIN
MEDICARE+CHOICE
CONTRACT
REQUIREMENTS.—
The following provisions of section 1857 shall apply,
subject to subsection (c)(5), to contracts under this
section in the same manner as they apply to con-
tracts under section 1857(a):
‘‘(A) 
MINIMUM
ENROLLMENT.—Para-
graphs (1) and (3) of section 1857(b).
‘‘(B) CONTRACT PERIOD AND EFFECTIVE-
NESS.—Paragraphs (1) through (3) and (5) of
section 1857(c).
‘‘(C) PROTECTIONS AGAINST FRAUD AND
BENEFICIARY PROTECTIONS.—Section 1857(d).
‘‘(D) ADDITIONAL
CONTRACT
TERMS.—
Section 1857(e); except that in applying section
1857(e)(2) under this part—
‘‘(i) such section shall be applied sepa-
rately to costs relating to this part (from
costs under part C);
‘‘(ii) in no case shall the amount of
the fee established under this subpara-
graph for a plan exceed 20 percent of the
maximum amount of the fee that may be
established under subparagraph (B) of
such section; and
‘‘(iii) no fees shall be applied under
this 
subparagraph 
with 
respect 
to
Medicare+Choice plans.
‘‘(E) INTERMEDIATE SANCTIONS.—Section
1857(g).
‘‘(F) PROCEDURES
FOR
TERMINATION.—
Section 1857(h).
‘‘(3) RULES
OF
APPLICATION
FOR
INTER-
MEDIATE
SANCTIONS.—In 
applying 
paragraph
(2)(E)—
‘‘(A) 
the 
reference 
in 
section
1857(g)(1)(B) to section 1854 is deemed a ref-
erence to this part; and
‘‘(B) 
the 
reference 
in 
section
1857(g)(1)(F) to section 1852(k)(2)(A)(ii) shall
not be applied.
‘‘(c) WAIVER OF CERTAIN REQUIREMENTS TO EX-
PAND CHOICE.—
‘‘(1) IN GENERAL.—In the case of an entity
that seeks to offer a prescription drug plan in a
State, the Medicare Benefits Administrator shall
waive the requirement of subsection (a)(1) that the
entity be licensed in that State if the Administrator
determines, based on the application and other evi-
dence presented to the Administrator, that any of
the grounds for approval of the application described
in paragraph (2) has been met.
‘‘(2) GROUNDS FOR APPROVAL.—The grounds
for approval under this paragraph are the grounds
for approval described in subparagraph (B), (C),
and (D) of section 1855(a)(2), and also include the
application by a State of any grounds other than
those required under Federal law.
‘‘(3) APPLICATION OF MEDICARE+CHOICE PSO
WAIVER PROCEDURES.—With respect to an applica-
tion for a waiver (or a waiver granted) under this
subsection, the provisions of subparagraphs (E), (F),
and (G) of section 1855(a)(2) shall apply.
‘‘(4) LICENSURE DOES NOT SUBSTITUTE FOR
OR CONSTITUTE CERTIFICATION.—The fact that an
entity is licensed in accordance with subsection
(a)(1) does not deem the entity to meet other re-
quirements imposed under this part for a PDP spon-
sor.
‘‘(5) REFERENCES TO CERTAIN PROVISIONS.—
For purposes of this subsection, in applying provi-
sions of section 1855(a)(2) under this subsection to
prescription drug plans and PDP sponsors—
‘‘(A) any reference to a waiver application
under section 1855 shall be treated as a ref-
erence to a waiver application under paragraph
(1); and
‘‘(B) any reference to solvency standards
were treated as a reference to solvency stand-
ards established under subsection (c).
‘‘(d) SOLVENCY STANDARDS
FOR NON-LICENSED
SPONSORS.—
‘‘(1) ESTABLISHMENT.—The Medicare Benefits
Administrator shall establish, by not later than Oc-
tober 1, 2001, financial solvency and capital ade-
quacy standards that an entity that does not meet
the requirements of subsection (a)(1) must meet to
qualify as a PDP sponsor under this part.
‘‘(2) COMPLIANCE
WITH
STANDARDS.—Each
PDP sponsor that is not licensed by a State under
subsection (a)(1) and for which a waiver application
has been approved under subsection (c) shall meet
solvency and capital adequacy standards established
under paragraph (1). The Medicare Benefits Admin-
istrator shall establish certification procedures for
such PDP sponsors with respect to such solvency
standards in the manner described in section
1855(c)(2).
‘‘(e) OTHER STANDARDS.—The Medicare Benefits
Administrator shall establish by regulation other stand-
ards (not described in subsection (d)) for PDP sponsors
and plans consistent with, and to carry out, this part. The
Administrator shall publish such regulations by October
1, 2001. In order to carry out this requirement in a timely
manner, the Administrator may promulgate regulations
that take effect on an interim basis, after notice and pend-
ing opportunity for public comment.
‘‘(f) RELATION TO STATE LAWS.—
‘‘(1) IN GENERAL.—The standards established
under this subsection shall supersede any State law
or regulation (including standards described in para-
graph (2)) with respect to prescription drug plans
which are offered by PDP sponsors under this part
to the extent such law or regulation is inconsistent
with such standards, in the same manner as such
laws and regulations are superseded under section
1856(b)(3).
‘‘(2) 
STANDARDS
SPECIFICALLY
SUPER-
SEDED.—State standards relating to the following
are superseded under this subsection:
‘‘(A) Benefit requirements.
‘‘(B) Requirements relating to inclusion or
treatment of providers.
‘‘(C) Coverage determinations (including
related appeals and grievance processes).
‘‘(3) PROHIBITION OF STATE IMPOSITION OF
PREMIUM TAXES.—No State may impose a premium
tax or similar tax with respect to premiums paid to
PDP sponsors for prescription drug plans under this
part, or with respect to any payments made to such
a sponsor by the Medicare Benefits Administrator
under this part.
‘‘SEC. 1860E. PROCESS FOR BENEFICIARIES TO SELECT
QUALIFIED PRESCRIPTION DRUG COVERAGE.
‘‘(a) IN GENERAL.—The Medicare Benefits Adminis-
trator, through the Office of Beneficiary Assistance, shall
establish, based upon and consistent with the procedures
used under part C (including section 1851), a process for
the 
selection 
of 
the 
prescription 
drug 
plan 
or
Medicare+Choice plan which offer qualified prescription
drug coverage through which eligible individuals elect
qualified prescription drug coverage under this part.
‘‘(b) ELEMENTS.—Such process shall include the fol-
lowing:
‘‘(1) Annual, coordinated election periods, in
which such individuals can change the qualifying
plans through which they obtain coverage, in accord-
ance with section 1860A(b)(2).
‘‘(2) Active dissemination of information to pro-
mote an informed selection among qualifying plans
based upon price, quality, and other features, in the
manner described in (and in coordination with) sec-
tion 1851(d), including the provision of annual com-
parative information, maintenance of a toll-free hot-
line, and the use of non-federal entities.
‘‘(3) Coordination of elections through filing
with a Medicare+Choice organization or a PDP
sponsor, in the manner described in (and in coordi-
nation with) section 1851(c)(2).
‘‘(c) MEDICARE+CHOICE ENROLLEE IN PLAN OF-
FERING PRESCRIPTION DRUG COVERAGE MAY ONLY OB-
TAIN BENEFITS THROUGH
THE PLAN.—An individual
who is enrolled under a Medicare+Choice plan that offers
qualified prescription drug coverage may only elect to re-
ceive qualified prescription drug coverage under this part
through such plan.
‘‘(d) ASSURING ACCESS TO A CHOICE OF QUALIFIED
PRESCRIPTION DRUG COVERAGE.—
‘‘(1) IN GENERAL.—The Medicare Benefits Ad-
ministrator shall assure that each individual who is
enrolled under part B and who is residing in an area
has available a choice of enrollment in at least 2
qualifying plans (as defined in paragraph (5)) in the
area in which the individual resides, at least 1 of
which is a prescription drug plan.
‘‘(2) GUARANTEEING ACCESS TO COVERAGE.—
In order to assure access under paragraph (1) and
consistent with paragraph (3), the Medicare Benefits
Administrator may provide financial incentives (in-
cluding partial underwriting of risk) for a PDP
sponsor to expand the service area under an existing
prescription drug plan to adjoining or additional
areas or to establish such a plan (including offering
such a plan on a regional or nationwide basis), but
only so long as (and to the extent) necessary to as-
sure the access guaranteed under paragraph (1).
‘‘(3) LIMITATION
ON
AUTHORITY.—In exer-
cising authority under this subsection, the Medicare
Benefits Administrator—
‘‘(A) shall not provide for the full under-
writing of financial risk for any PDP sponsor;
‘‘(B) shall not provide for any under-
writing of financial risk for a public PDP spon-
sor with respect to the offering of a nationwide
prescription drug plan; and
‘‘(C) shall seek to maximize the assump-
tion of financial risk by PDP sponsors or
Medicare+Choice organizations.
‘‘(4) REPORTS.—The Medicare Benefits Admin-
istrator shall, in each annual report to Congress
under section 1807(f), include information on the
exercise of authority under this subsection. The Ad-
ministrator also shall include such recommendations
as may be appropriate to minimize the exercise of
such authority, including minimizing the assumption
of financial risk.
‘‘(5) QUALIFYING
PLAN
DEFINED.—For pur-
poses of this subsection, the term ‘qualifying plan’
means 
a 
prescription 
drug 
plan 
or 
a 
a
Medicare+Choice plan that includes qualified pre-
scription drug coverage.
‘‘SEC. 1860F. PREMIUMS.
‘‘(a) SUBMISSION OF PREMIUMS AND RELATED IN-
FORMATION.—
‘‘(1) IN GENERAL.—Each PDP sponsor shall
submit to the Medicare Benefits Administrator in-
formation of the type described in paragraph (2) in
the same manner as information is submitted by a
Medicare+Choice 
organization 
under 
section
1854(a)(1).
‘‘(2) TYPE OF INFORMATION.—The information
described in this paragraph is the following:
‘‘(A) Information on the qualified prescrip-
tion drug coverage to be provided.
‘‘(B) Information on the actuarial value of
the coverage.
‘‘(C) Information on the monthly premium
to be charged for the coverage, including an ac-
tuarial certification of—
‘‘(i) the actuarial basis for such pre-
mium;
‘‘(ii) the portion of such premium at-
tributable to benefits in excess of standard
coverage; and
‘‘(iii) the reduction in such premium
resulting from the reinsurance subsidy
payments provided under section 1860H.
‘‘(D) Such other information as the Medi-
care Benefits Administrator may require to
carry out this part.
‘‘(3) REVIEW.—The Medicare Benefits Admin-
istrator shall review the information filed under
paragraph (2) and shall approve or disapprove such
rates, amounts, and values so submitted. In exer-
cising such authority, the Administrator shall take
into account the reinsurance subsidy payments
under section 1860H and the adjusted community
rate (as defined in section 1854(f)(3)) for the bene-
fits covered and shall have the same authority to ne-
gotiate the terms and conditions of such premiums
and other terms and conditions of plans as the Di-
rector of the Office of Personnel Management has
with respect to health benefits plans under chapter
89 of title 5, United States Code.
‘‘(b) UNIFORM PREMIUM.—The premium for a pre-
scription drug plan charged under this section may not
vary among individuals enrolled in the plan in the same
service area, except as is permitted under section
1860A(c)(2)(B) (relating to late enrollment penalties).
‘‘(c) TERMS AND CONDITIONS FOR IMPOSING PRE-
MIUMS.—The provisions of section 1854(d) shall apply
under this part in the same manner as they apply under
part C, and, for this purpose, the reference in such section
to section 1851(g)(3)(B)(i) is deemed a reference to sec-
tion 1860A(d)(3)(B) (relating to failure to pay premiums
required under this part).
‘‘(d) ACCEPTANCE
OF REFERENCE PREMIUM
AS
FULL PREMIUM IF NO STANDARD (OR EQUIVALENT) COV-
ERAGE IN AN AREA.—
‘‘(1) IN GENERAL.—If there is no standard pre-
scription drug coverage (as defined in paragraph
(2)) offered in an area, in the case of an individual
who is eligible for a premium subsidy under section
1860G and resides in the area, the PDP sponsor of
any prescription drug plan offered in the area (and
any Medicare+Choice organization that offers quali-
fied prescription drug coverage in the area) shall ac-
cept 
the 
reference 
premium 
under 
section
1860G(b)(2) as payment in full for the premium
charge for qualified prescription drug coverage.
‘‘(2) STANDARD
PRESCRIPTION
DRUG
COV-
ERAGE DEFINED.—For purposes of this subsection,
the term ‘standard prescription drug coverage’
means qualified prescription drug coverage that is
standard coverage or that has an actuarial value
equivalent to the actuarial value for standard cov-
erage.
‘‘SEC. 1860G. PREMIUM AND COST-SHARING SUBSIDIES FOR
LOW-INCOME INDIVIDUALS.
‘‘(a) IN GENERAL.—
‘‘(1) FULL PREMIUM SUBSIDY AND REDUCTION
OF COST-SHARING FOR INDIVIDUALS WITH INCOME
BELOW
135
PERCENT
OF
FEDERAL
POVERTY
LEVEL.—In the case of a subsidy eligible individual
(as defined in paragraph (3)) who is determined to
have income that does not exceed 135 percent of the
Federal poverty level, the individual is entitled under
this section—
‘‘(A) to a premium subsidy equal to 100
percent of the amount described in subsection
(b)(1); and
‘‘(B) subject to subsection (c), to the sub-
stitution for the beneficiary cost-sharing de-
scribed in paragraphs (1) and (2) of section
1860B(b) (up to the initial coverage limit speci-
fied in paragraph (3) of such section) of
amounts that are nominal.
‘‘(2) SLIDING
SCALE
PREMIUM
SUBSIDY
FOR
INDIVIDUALS WITH INCOME ABOVE 135, BUT BELOW
150
PERCENT, OF
FEDERAL
POVERTY
LEVEL.—In
the case of a subsidy eligible individual who is deter-
mined to have income that exceeds 135 percent, but
does not exceed 150 percent, of the Federal poverty
level, the individual is entitled under this section to
a premium subsidy determined on a linear sliding
scale ranging from 100 percent of the amount de-
scribed in subsection (b)(1) for individuals with in-
comes at 135 percent of such level to 0 percent of
such amount for individuals with incomes at 150
percent of such level.
‘‘(3) DETERMINATION OF ELIGIBILITY.—
‘‘(A) SUBSIDY ELIGIBLE INDIVIDUAL DE-
FINED.—For purposes of this section, subject
to subparagraph (D), the term ‘subsidy eligible
individual’ means an individual who—
‘‘(i) is eligible to elect, and has elect-
ed, to obtain qualified prescription drug
coverage under this part;
‘‘(ii) has income below 150 percent of
the Federal poverty line; and
‘‘(iii) meets the resources requirement
described in section 1905(p)(1)(C).
‘‘(B) DETERMINATIONS.—The determina-
tion of whether an individual residing in a State
is a subsidy eligible individual and the amount
of such individual’s income shall be determined
under the State medicaid plan for the State
under section 1935(a). In the case of a State
that does not operate such a medicaid plan (ei-
ther under title XIX or under a statewide waiv-
er granted under section 1115), such deter-
mination shall be made under arrangements
made by the Medicare Benefits Administrator.
‘‘(C) INCOME DETERMINATIONS.—For pur-
poses of applying this section—
‘‘(i) income shall be determined in the
manner 
described 
in 
section
1905(p)(1)(B); and
‘‘(ii) the term ‘Federal poverty line’
means the official poverty line (as defined
by the Office of Management and Budget,
and revised annually in accordance with
section 673(2) of the Omnibus Budget
Reconciliation Act of 1981) applicable to a
family of the size involved.
‘‘(D) TREATMENT OF TERRITORIAL RESI-
DENTS.—In the case of an individual who is not
a resident of the 50 States or the District of
Columbia, the individual is not eligible to be a
subsidy eligible individual but may be eligible
for financial assistance with prescription drug
expenses under section 1935(e).
‘‘(b) PREMIUM SUBSIDY AMOUNT.—
‘‘(1) IN
GENERAL.—The premium subsidy
amount described in this subsection for an individual
residing in an area is the reference premium (as de-
fined in paragraph (2)) for qualified prescription
drug coverage offered by the prescription drug plan
or the Medicare+Choice plan in which the individual
is enrolled.
‘‘(2) REFERENCE
PREMIUM
DEFINED.—For
purposes of this subsection, the term ‘reference pre-
mium’ means, with respect to qualified prescription
drug coverage offered under—
‘‘(A) a prescription drug plan that—
‘‘(i) provides standard coverage (or al-
ternative prescription drug coverage the
actuarial value is equivalent to that of
standard coverage), the premium imposed
for enrollment under the plan under this
part (determined without regard to any
subsidy under this section or any late en-
rollment 
penalty 
under 
section
1860A(c)(2)(B)); or
‘‘(ii) provides alternative prescription
drug coverage the actuarial value of which
is greater than that of standard coverage,
the premium described in clause (i) multi-
plied by the ratio of (I) the actuarial value
of standard coverage, to (II) the actuarial
value of the alternative coverage; or
‘‘(B) a Medicare+Choice plan, the stand-
ard 
premium 
computed 
under 
section
1851(j)(4)(A)(iii), determined without regard to
any 
reduction 
effected 
under 
section
1851(j)(4)(B).
‘‘(c) RULES
IN
APPLYING
COST-SHARING
SUB-
SIDIES.—
‘‘(1) IN
GENERAL.—In applying subsection
(a)(1)(B)—
‘‘(A) the maximum amount of subsidy that
may be provided with respect to an enrollee for
a year may not exceed 95 percent of the max-
imum cost-sharing described in such subsection
that may be incurred for standard coverage;
‘‘(B) the Medicare Benefits Administrator
shall determine what is ‘nominal’ taking into
account 
the 
rules 
applied 
under 
section
1916(a)(3); and
‘‘(C) nothing in this part shall be con-
strued as preventing a plan or provider from
waiving or reducing the amount of cost-sharing
otherwise applicable.
‘‘(2) LIMITATION ON CHARGES.—In the case of
an individual receiving cost-sharing subsidies under
subsection (a)(1)(B), the PDP sponsor may not
charge more than a nominal amount in cases in
which the cost-sharing subsidy is provided under
such subsection.
‘‘(d) ADMINISTRATION OF SUBSIDY PROGRAM.—The
Medicare Benefits Administrator shall provide a process
whereby, in the case of an individual who is determined
to be a subsidy eligible individual and who is enrolled in
prescription drug plan or is enrolled in a Medicare+Choice
plan under which qualified prescription drug coverage is
provided—
‘‘(1) the Administrator provides for a notifica-
tion of the PDP sponsor or Medicare+Choice orga-
nization involved that the individual is eligible for a
subsidy and the amount of the subsidy under sub-
section (a);
‘‘(2) the sponsor or organization involved re-
duces the premiums or cost-sharing otherwise im-
posed by the amount of the applicable subsidy and
submits to the Administrator information on the
amount of such reduction; and
‘‘(3) the Administrator periodically and on a
timely basis reimburses the sponsor or organization
for the amount of such reductions.
The reimbursement under paragraph (3) with respect to
cost-sharing subsidies may be computed on a capitated
basis, taking into account the actuarial value of the sub-
sidies and with appropriate adjustments to reflect dif-
ferences in the risks actually involved.
‘‘(e) RELATION TO MEDICAID PROGRAM.—
‘‘(1) IN
GENERAL.—For provisions providing
for eligibility determinations, and additional financ-
ing, under the medicaid program, see section 1935.
‘‘(2) MEDICAID PROVIDING WRAP AROUND BEN-
EFITS.—The coverage provided under this part is
primary payor to benefits for prescribed drugs pro-
vided under the medicaid program under title XIX.
‘‘SEC. 
1860H. 
SUBSIDIES 
FOR 
ALL 
MEDICARE 
BENE-
FICIARIES 
THROUGH 
REINSURANCE 
FOR
QUALIFIED PRESCRIPTION DRUG COVERAGE.
‘‘(a) REINSURANCE SUBSIDY PAYMENT.—In order to
reduce premium levels applicable to qualified prescription
drug coverage for all medicare beneficiaries, to reduce ad-
verse selection among prescription drug plans and
Medicare+Choice plans that provide qualified prescription
drug coverage, and to promote the participation of PDP
sponsors under this part, the Medicare Benefits Adminis-
trator shall provide in accordance with this section for
payment to a qualifying entity (as defined in subsection
(b)) of the reinsurance payment amount (as defined in
subsection (c)) for excess costs incurred in providing quali-
fied prescription drug coverage—
‘‘(1) for individuals enrolled with a prescription
drug plan under this part;
‘‘(2) 
for 
individuals 
enrolled 
with 
a
Medicare+Choice plan that provides qualified pre-
scription drug coverage under part C; and
‘‘(3) for medicare primary individuals (de-
scribed in subsection (f)(3)(D)) who are enrolled in
a qualified retiree prescription drug plan.
This section constitutes budget authority in advance of ap-
propriations Acts and represents the obligation of the Ad-
ministrator to provide for the payment of amounts pro-
vided under this section.
‘‘(b) QUALIFYING ENTITY DEFINED.—For purposes
of this section, the term ‘qualifying entity’ means any of
the following that has entered into an agreement with the
Administrator to provide the Administrator with such in-
formation as may be required to carry out this section:
‘‘(1) A PDP sponsor offering a prescription
drug plan under this part.
‘‘(2) A Medicare+Choice organization that pro-
vides qualified prescription drug coverage under a
Medicare+Choice plan under part C.
‘‘(3) The sponsor of a qualified retiree prescrip-
tion drug plan (as defined in subsection (f)).
‘‘(c) REINSURANCE PAYMENT AMOUNT.—
‘‘(1) IN
GENERAL.—Subject to subsection
(d)(2) and paragraph (4), the reinsurance payment
amount under this subsection for a qualifying cov-
ered individual (as defined in subsection (g)(1)) for
a coverage year (as defined in subsection (g)(2)) is
equal to the sum of the following:
‘‘(A) For the portion of the individual’s
gross covered prescription drug costs (as de-
fined in paragraph (3)) for the year that ex-
ceeds $1,250, but does not exceed $1,350, an
amount equal to 30 percent of the allowable
costs (as defined in paragraph (2)) attributable
to such gross covered prescription drug costs.
‘‘(B) For the portion of the individual’s
gross covered prescription drug costs for the
year that exceeds $1,350, but does not exceed
$1,450, an amount equal to 50 percent of the
allowable costs attributable to such gross cov-
ered prescription drug costs.
‘‘(C) For the portion of the individual’s
gross covered prescription drug costs for the
year that exceeds $1,450, but does not exceed
$1,550, an amount equal to 70 percent of the
allowable costs attributable to such gross cov-
ered prescription drug costs.
‘‘(D) For the portion of the individual’s
gross covered prescription drug costs for the
year that exceeds $1,550, but does not exceed
$2,350, an amount equal to 90 percent of the
allowable costs attributable to such gross cov-
ered prescription drug costs.
‘‘(E) For the portion of the individual’s
gross covered prescription drug costs for the
year that exceeds $7,050, an amount equal to
90 percent of the allowable costs attributable to
such gross covered prescription drug costs.
‘‘(2) ALLOWABLE COSTS.—For purposes of this
section, the term ‘allowable costs’ means, with re-
spect to gross covered prescription drug costs under
a plan described in subsection (b) offered by a quali-
fying entity, the part of such costs that are actually
paid under the plan, but in no case more than the
part of such costs that would have been paid under
the plan if the prescription drug coverage under the
plan were standard coverage.
‘‘(3) GROSS
COVERED
PRESCRIPTION
DRUG
COSTS.—For purposes of this section, the term
‘gross covered prescription drug costs’ means, with
respect to an enrollee with a qualifying entity under
a plan described in subsection (b) during a coverage
year, the costs incurred under the plan for covered
prescription drugs dispensed during the year, includ-
ing costs relating to the deductible, whether paid by
the enrollee or under the plan, regardless of whether
the coverage under the plan exceeds standard cov-
erage and regardless of when the payment for such
drugs is made.
‘‘(4) INDEXING DOLLAR AMOUNTS.—
‘‘(A) AMOUNTS
FOR
2003.—The dollar
amounts applied under paragraph (1) for 2003
shall be the dollar amounts specified in such
paragraph.
‘‘(B) FOR 2004.—The dollar amounts ap-
plied under paragraph (1) for 2004 shall be the
dollar amounts specified in such paragraph in-
creased by the annual percentage increase de-
scribed in section 1860B(b)(5) for 2004.
‘‘(C) FOR SUBSEQUENT YEARS.—The dol-
lar amounts applied under paragraph (1) for a
year after 2004 shall be the amounts (under
this paragraph) applied under paragraph (1)
for the preceding year increased by the annual
percentage 
increase 
described 
in 
section
1860B(b)(5) for the year involved.
‘‘(D) ROUNDING.—Any amount, deter-
mined under the preceding provisions of this
paragraph for a year, which is not a multiple of
$5 shall be rounded to the nearest multiple of
$5.
‘‘(d) ADJUSTMENT OF PAYMENTS.—
‘‘(1) IN GENERAL.—The Medicare Benefits Ad-
ministrator shall estimate—
‘‘(A) the total payments to be made (with-
out regard to this subsection) during a year
under this section; and
‘‘(B) the total payments to be made by
qualifying entities for standard coverage under
plans described in subsection (b) during the
year.
‘‘(2) ADJUSTMENT
OF
PAYMENTS.—The Ad-
ministrator shall proportionally adjust the payments
made under this section for a coverage year in such
manner so that the total of the payments made for
the year under this section is equal to 35 percent of
the total payments described in paragraph (1)(B)
during the year.
‘‘(e) PAYMENT METHODS.—
‘‘(1) IN GENERAL.—Payments under this sec-
tion shall be based on such a method as the Medi-
care Benefits Administrator determines. The Admin-
istrator may establish a payment method by which
interim payments of amounts under this section are
made during a year based on the Administrator’s
best estimate of amounts that will be payable after
obtaining all of the information.
‘‘(2) SOURCE OF PAYMENTS.—Payments under
this section shall be made from the Medicare Pre-
scription Drug Account.
‘‘(f) QUALIFIED
RETIREE
PRESCRIPTION
DRUG
PLAN DEFINED.—
‘‘(1) IN GENERAL.—For purposes of this sec-
tion, the term ‘qualified retiree prescription drug
plan’ means employment-based retiree health cov-
erage (as defined in paragraph (3)(A)) if, with re-
spect to an individual enrolled (or eligible to be en-
rolled) under this part who is covered under the
plan, the following requirements are met:
‘‘(A) ASSURANCE.—The sponsor of the
plan shall annually attest, and provide such as-
surances as the Medicare Benefits Adminis-
trator may require, that the coverage meets the
requirements for qualified prescription drug
coverage.
‘‘(B) AUDITS.—The sponsor (and the plan)
shall maintain, and afford the Medicare Bene-
fits Administrator access to, such records as the
Administrator may require for purposes of au-
dits and other oversight activities necessary to
ensure the adequacy of prescription drug cov-
erage, the accuracy of payments made, and
such other matters as may be appropriate.
‘‘(C) PROVISION
OF
CERTIFICATION
OF
PRESCRIPTION DRUG COVERAGE.—The sponsor
of the plan shall provide for issuance of certifi-
cations of the type described in section
1860A(c)(2)(D).
‘‘(D) OTHER REQUIREMENTS.—The spon-
sor of the plan shall comply with such other re-
quirements as the Medicare Benefits Adminis-
trator finds necessary to administer the pro-
gram under this section.
‘‘(2) LIMITATION ON BENEFIT ELIGIBILITY.—
No payment shall be provided under this section
with respect to an individual who is enrolled under
a qualified retiree prescription drug plan unless the
individual is a medicare primary individual who—
‘‘(A) is covered under the plan; and
‘‘(B) is eligible to obtain qualified prescrip-
tion drug coverage under section 1860A but did
not elect such coverage under this part (either
through a prescription drug plan or through a
Medicare+Choice plan).
‘‘(3) DEFINITIONS.—As used in this section:
‘‘(A) 
EMPLOYMENT-BASED
RETIREE
HEALTH
COVERAGE.—The term ‘employment-
based retiree health coverage’ means health in-
surance or other coverage of health care costs
for medicare primary individuals (or for such
individuals and their spouses and dependents)
based on their status as former employees or
labor union members.
‘‘(B) EMPLOYER.—The term ‘employer’
has the meaning given such term by section
3(5) of the Employee Retirement Income Secu-
rity Act of 1974 (except that such term shall
include only employers of two or more employ-
ees).
‘‘(C) 
SPONSOR.—The 
term 
‘sponsor’
means a plan sponsor, as defined in section
3(16)(B) of the Employee Retirement Income
Security Act of 1974.
‘‘(D) MEDICARE PRIMARY INDIVIDUAL.—
The term ‘medicare primary individual’ means,
with respect to a plan, an individual who is cov-
ered under the plan and with respect to whom
the plan is not a primary plan (as defined in
section 1862(b)(2)(A)).
‘‘(g) GENERAL DEFINITIONS.—For purposes of this
section:
‘‘(1) QUALIFYING COVERED INDIVIDUAL.—The
term ‘qualifying covered individual’ means an indi-
vidual who—
‘‘(A) is enrolled with a prescription drug
plan under this part;
‘‘(B) is enrolled with a Medicare+Choice
plan that provides qualified prescription drug
coverage under part C; or
‘‘(C) is covered as a medicare primary in-
dividual under a qualified retiree prescription
drug plan.
‘‘(2) COVERAGE
YEAR.—The term ‘coverage
year’ means a calendar year in which covered out-
patient drugs are dispensed if a claim for payment
is made under the plan for such drugs, regardless of
when the claim is paid.
‘‘SEC. 1860I. MEDICARE PRESCRIPTION DRUG ACCOUNT IN
FEDERAL SUPPLEMENTARY MEDICAL INSUR-
ANCE TRUST FUND.
‘‘(a) IN GENERAL.—There is created within the Fed-
eral Supplementary Medical Insurance Trust Fund estab-
lished by section 1841 an account to be known as the
‘Medicare Prescription Drug Account’ (in this section re-
ferred to as the ‘Account’). The Account shall consist of
such gifts and bequests as may be made as provided in
section 201(i)(1), and such amounts as may be deposited
in, or appropriated to, such fund as provided in this part.
Funds provided under this part to the Account shall be
kept separate from all other funds within the Federal Sup-
plementary Medical Insurance Trust Fund.
‘‘(b) PAYMENTS FROM ACCOUNT.—
‘‘(1) IN
GENERAL.—The Managing Trustee
shall pay from time to time from the Account such
amounts as the Medicare Benefits Administrator
certifies are necessary to make—
‘‘(A) payments under section 1860G (relat-
ing to low-income subsidy payments);
‘‘(B) payments under section 1860H (re-
lating to reinsurance subsidy payments); and
‘‘(C) payments with respect to administra-
tive expenses under this part in accordance with
section 201(g).
‘‘(2) TRANSFERS TO MEDICAID ACCOUNT FOR
INCREASED
ADMINISTRATIVE
COSTS.—The Man-
aging Trustee shall transfer from time to time from
the Account to the Grants to States for Medicaid ac-
count amounts the Secretary certifies are attrib-
utable to increases in payment resulting from the
application of a higher Federal matching percentage
under section 1935(b).
‘‘(c) DEPOSITS INTO ACCOUNT.—
‘‘(1) MEDICAID
TRANSFER.—There is hereby
transferred to the Account, from amounts appro-
priated for Grants to States for Medicaid, amounts
equivalent to the aggregate amount of the reductions
in payments under section 1903(a)(1) attributable to
the application of section 1935(c).
‘‘(2) APPROPRIATIONS TO COVER GOVERNMENT
CONTRIBUTIONS.—There are authorized to be appro-
priated from time to time, out of any moneys in the
Treasury not otherwise appropriated, to the Ac-
count, an amount equivalent to the amount of pay-
ments made from the Account under subsection (b),
reduced by the amount transferred to the Account
under paragraph (1).
‘‘SEC. 1860J. DEFINITIONS; TREATMENT OF REFERENCES
TO PROVISIONS IN PART C.
‘‘(a) DEFINITIONS.—For purposes of this part:
‘‘(1) COVERED OUTPATIENT DRUGS.—The term
‘covered outpatient drugs’ is defined in section
1860B(f).
‘‘(2) INITIAL COVERAGE LIMIT.—The term ‘ini-
tial coverage limit’ means the such limit as estab-
lished under section 1860B(b)(3), or, in the case of
coverage that is not standard coverage, the com-
parable limit (if any) established under the coverage.
‘‘(3) MEDICARE
PRESCRIPTION
DRUG
AC-
COUNT.—The term ‘Medicare Prescription Drug Ac-
count’ means the Account in the Federal Supple-
mentary Medical Insurance Trust Fund created
under section 1860I(a).
‘‘(4) PDP SPONSOR.—The term ‘PDP sponsor’
means an entity that is certified under this part as
meeting the requirements and standards of this part
for such a sponsor.
‘‘(5) PRESCRIPTION
DRUG
PLAN.—The term
‘prescription drug plan’ means health benefits cov-
erage that—
‘‘(A) is offered under a policy, contract, or
plan by a PDP sponsor pursuant to, and in ac-
cordance with, a contract between the Medicare
Benefits Administrator and the sponsor under
section 1860D(b);
‘‘(B) provides qualified prescription drug
coverage; and
‘‘(C) meets the applicable requirements of
the section 1860C for a prescription drug plan.
‘‘(6) QUALIFIED
PRESCRIPTION
DRUG
COV-
ERAGE.—The term ‘qualified prescription drug cov-
erage’ is defined in section 1860B(a).
‘‘(7) STANDARD COVERAGE.—The term ‘stand-
ard coverage’ is defined in section 1860B(b).
‘‘(b) APPLICATION OF MEDICARE+CHOICE PROVI-
SIONS UNDER THIS PART.—For purposes of applying pro-
visions of part C under this part with respect to a pre-
scription drug plan and a PDP sponsor, unless otherwise
provided in this part such provisions shall be applied as
if—
‘‘(1) any reference to a Medicare+Choice plan
included a reference to a prescription drug plan;
‘‘(2) any reference to a provider-sponsored or-
ganization included a reference to a PDP sponsor;
‘‘(3) any reference to a contract under section
1857 included a reference to a contract under sec-
tion 1860D(b); and
‘‘(4) any reference to part C included a ref-
erence to this part.’’.
(c) CONFORMING AMENDMENTS TO FEDERAL SUP-
PLEMENTARY MEDICAL INSURANCE TRUST FUND.—Sec-
tion 1841 of the Social Security Act (42 U.S.C. 1395t)
is amended—
(1) in the last sentence of subsection (a)—
(A) by striking ‘‘and’’ before ‘‘such
amounts’’, and
(B) by inserting before the period the fol-
lowing: ‘‘and such amounts as may be deposited
in, or appropriated to, the Medicare Prescrip-
tion Drug Account established by section
1860I’’; and
(2) in subsection (g), by inserting after ‘‘by this
part,’’ the following: ‘‘the payments provided for
under part D (in which case the payments shall
come from the Medicare Prescription Drug Account
in the Trust Fund),’’.
(d) ADDITIONAL CONFORMING CHANGES.—
(1) CONFORMING
REFERENCES
TO
PREVIOUS
PART D.—Any reference in law (in effect before the
date of the enactment of this Act) to part D of title
XVIII of the Social Security Act is deemed a ref-
erence to part E of such title (as in effect after such
date).
(2) SECRETARIAL SUBMISSION OF LEGISLATIVE
PROPOSAL.—Not later than 6 months after the date
of the enactment of this Act, the Secretary of
Health and Human Services shall submit to the ap-
propriate committees of Congress a legislative pro-
posal providing for such technical and conforming
amendments in the law as are required by the provi-
sions of this subtitle.
SEC. 102. OFFERING OF QUALIFIED PRESCRIPTION DRUG
COVERAGE UNDER THE MEDICARE+CHOICE
PROGRAM.
(a) IN GENERAL.—Section 1851 of the Social Secu-
rity Act (42 U.S.C. 1395w–21) is amended by adding at
the end the following new subsection:
‘‘(j) AVAILABILITY OF PRESCRIPTION DRUG BENE-
FITS.—
‘‘(1) IN GENERAL.—A Medicare+Choice orga-
nization may not offer prescription drug coverage
(other than that required under parts A and B) to
an enrollee under a Medicare+Choice plan unless
such drug coverage is at least qualified prescription
drug coverage and unless the requirements of this
subsection with respect to such coverage are met.
‘‘(2) COMPLIANCE
WITH
ADDITIONAL
BENE-
FICIARY PROTECTIONS.—With respect to the offer-
ing of qualified prescription drug coverage by a
Medicare+Choice 
organization 
under 
a
Medicare+Choice plan, the organization and plan
shall meet the requirements of section 1860C, in-
cluding requirements relating to information dis-
semination and grievance and appeals, in the same
manner as they apply to a PDP sponsor and a pre-
scription drug plan under part D. The Medicare
Benefits Administrator shall waive such require-
ments to the extent the Administrator determines
that such requirements duplicate requirements oth-
erwise applicable to the organization or plan under
this part.
‘‘(3) TREATMENT
OF
COVERAGE.—Except as
provided in this subsection, qualified prescription
drug coverage offered under this subsection shall be
treated under this part in the same manner as sup-
plemental health care benefits described in section
1852(a)(3)(A).
‘‘(4) AVAILABILITY
OF
PREMIUM
AND
COST-
SHARING SUBSIDIES FOR LOW-INCOME ENROLLEES
AND REINSURANCE SUBSIDY PAYMENTS FOR ORGA-
NIZATIONS.—For provisions—
‘‘(A) providing premium and cost-sharing
subsidies to low-income individuals receiving
qualified prescription drug coverage through a
Medicare+Choice plan, see section 1860G; and
‘‘(B) providing a Medicare+Choice organi-
zation with reinsurance subsidy payments for
providing qualified prescription drug coverage
under this part, see section 1860H.
‘‘(5) SPECIFICATION OF SEPARATE AND STAND-
ARD PREMIUM.—
‘‘(A) IN GENERAL.—For purposes of ap-
plying section 1854 and section 1860G(b)(2)(B)
with respect to qualified prescription drug cov-
erage offered under this subsection under a
plan, the Medicare+Choice organization shall
compute and publish the following:
‘‘(i) SEPARATE
PRESCRIPTION
DRUG
PREMIUM.—A premium for prescription
drug benefits that constitute qualified pre-
scription drug coverage that is separate
from other coverage under the plan.
‘‘(ii) PORTION OF COVERAGE ATTRIB-
UTABLE
TO
STANDARD
BENEFITS.—The
ratio of the actuarial value of standard
coverage to the actuarial value of the
qualified prescription drug coverage offered
under the plan.
‘‘(iii) PORTION OF PREMIUM ATTRIB-
UTABLE
TO
STANDARD
BENEFITS.—A
standard premium equal to the product of
the premium described in clause (i) and
the ratio under clause (ii).
The premium under clause (i) shall be compute
without regard to any reduction in the premium
permitted under subparagraph (B).
‘‘(B) 
REDUCTION
OF
PREMIUMS
AL-
LOWED.—Nothing in this subsection shall be
construed as preventing a Medicare+Choice or-
ganization from reducing the amount of a pre-
mium charged for prescription drug coverage
because 
of 
the 
application 
of 
section
1854(f)(1)(A) to other coverage.
‘‘(C) ACCEPTANCE
OF
REFERENCE
PRE-
MIUM AS FULL PREMIUM IF NO STANDARD (OR
EQUIVALENT) COVERAGE IN AN AREA.—For re-
quirement to accept reference premium as full
premium if there is no standard (or equivalent)
coverage in the area of a Medicare+Choice
plan, see section 1860F(d).
‘‘(6) TRANSITION IN INITIAL ENROLLMENT PE-
RIOD.—Notwithstanding any other provision of this
part, the annual, coordinated election period under
subsection (e)(3)(B) for 2003 shall be the 6-month
period beginning with November 2002.
‘‘(7) QUALIFIED
PRESCRIPTION
DRUG
COV-
ERAGE; STANDARD
COVERAGE.—For purposes of
this part, the terms ‘qualified prescription drug cov-
erage’ and ‘standard coverage’ have the meanings
given such terms in section 1860B.’’.
(b) CONFORMING AMENDMENTS.—Section 1851 of
such Act (42 U.S.C. 1395w–21) is amended—
(1) in subsection (a)(1)—
(A) by inserting ‘‘(other than qualified pre-
scription drug benefits)’’ after ‘‘benefits’’;
(B) by striking the period at the end of
subparagraph (B) and inserting a comma; and
(C) by adding after and below subpara-
graph (B) the following:
‘‘and may elect qualified prescription drug coverage
in accordance with section 1860A.’’; and
(2) in subsection (g)(1), by inserting ‘‘and sec-
tion 1860A(c)(2)(B)’’ after ‘‘in this subsection’’.
(c) EFFECTIVE DATE.—The amendments made by
this section apply to coverage provided on or after January
1, 2003.
SEC. 103. MEDICAID AMENDMENTS.
(a) DETERMINATIONS OF ELIGIBILITY FOR LOW-IN-
COME SUBSIDIES.—
(1) REQUIREMENT.—Section 1902 of the Social
Security Act (42 U.S.C. 1396a) is amended—
(A) in subsection (a)—
(i) by striking ‘‘and’’ at the end of
paragraph (64);
(ii) by striking the period at the end
of paragraph (65) and inserting ‘‘; and’’;
and
(iii) by inserting after paragraph (65)
the following new paragraph:
‘‘(66) provide for making eligibility determina-
tions under section 1935(a).’’.
(2) NEW SECTION.—Title XIX of such Act is
further amended—
(A) by redesignating section 1935 as sec-
tion 1936; and
(B) by inserting after section 1934 the fol-
lowing new section:
‘‘SPECIAL PROVISIONS RELATING TO MEDICARE
PRESCRIPTION DRUG BENEFIT
‘‘SEC. 1935. (a) REQUIREMENT FOR MAKING ELIGI-
BILITY
DETERMINATIONS
FOR
LOW-INCOME
SUB-
SIDIES.—As a condition of its State plan under this title
under section 1902(a)(66) and receipt of any Federal fi-
nancial assistance under section 1903(a), a State shall—
‘‘(1) make determinations of eligibility for pre-
mium and cost-sharing subsidies under (and in ac-
cordance with) section 1860G;
‘‘(2) inform the Administrator of the Medicare
Benefits Administration of such determinations in
cases in which such eligibility is established; and
‘‘(3) otherwise provide such Administrator with
such information as may be required to carry out
part D of title XVIII (including section 1860G).
‘‘(b) PAYMENTS FOR ADDITIONAL ADMINISTRATIVE
COSTS.—
‘‘(1) IN GENERAL.—The amounts expended by
a State in carrying out subsection (a) are, subject to
paragraph (2), expenditures reimbursable under the
appropriate paragraph of section 1903(a); except
that, notwithstanding any other provision of such
section, the applicable Federal matching rates with
respect to such expenditures under such section shall
be increased as follows:
‘‘(A) For expenditures attributable to costs
incurred during 2003, the otherwise applicable
Federal matching rate shall be increased by 20
percent of the percentage otherwise payable
(but for this subsection) by the State.
‘‘(B) For expenditures attributable to costs
incurred during 2004, the otherwise applicable
Federal matching rate shall be increased by 40
percent of the percentage otherwise payable
(but for this subsection) by the State.
‘‘(C) For expenditures attributable to costs
incurred during 2005, the otherwise applicable
Federal matching rate shall be increased by 60
percent of the percentage otherwise payable
(but for this subsection) by the State.
‘‘(D) For expenditures attributable to costs
incurred during 2006, the otherwise applicable
Federal matching rate shall be increased by 80
percent of the percentage otherwise payable
(but for this subsection) by the State.
‘‘(E) For expenditures attributable to costs
incurred after 2006, the otherwise applicable
Federal matching rate shall be increased to 100
percent.
‘‘(2) COORDINATION.—The State shall provide
the Secretary with such information as may be nec-
essary to properly allocate administrative expendi-
tures described in paragraph (1) that may otherwise
be made for similar eligibility determinations.’’.
(b) PHASED-IN FEDERAL ASSUMPTION OF MEDICAID
RESPONSIBILITY FOR PREMIUM AND COST-SHARING SUB-
SIDIES FOR DUALLY ELIGIBLE INDIVIDUALS.—
(1) IN GENERAL.—Section 1903(a)(1) of the
Social Security Act (42 U.S.C. 1396b(a)(1)) is
amended by inserting before the semicolon the fol-
lowing: ‘‘, reduced by the amount computed under
section 1935(c)(1) for the State and the quarter’’.
(2) AMOUNT
DESCRIBED.—Section 1935 of
such Act, as inserted by subsection (a)(2), is amend-
ed by adding at the end the following new sub-
section:
‘‘(c) FEDERAL ASSUMPTION
OF MEDICAID PRE-
SCRIPTION DRUG COSTS FOR DUALLY-ELIGIBLE BENE-
FICIARIES.—
‘‘(1) IN
GENERAL.—For purposes of section
1903(a)(1), for a State that is one of the 50 States
or the District of Columbia for a calendar quarter
in a year (beginning with 2003) the amount com-
puted under this subsection is equal to the product
of the following:
‘‘(A) MEDICARE
SUBSIDIES.—The total
amount of payments made in the quarter under
section 1860G (relating to premium and cost-
sharing prescription drug subsidies for low-in-
come medicare beneficiaries) that are attrib-
utable to individuals who are residents of the
State and are entitled to benefits with respect
to prescribed drugs under the State plan under
this title (including such a plan operating under
a waiver under section 1115).
‘‘(B) STATE MATCHING RATE.—A propor-
tion computed by subtracting from 100 percent
the Federal medical assistance percentage (as
defined in section 1905(b)) applicable to the
State and the quarter.
‘‘(C) 
PHASE-OUT
PROPORTION.—The
phase-out proportion (as defined in paragraph
(2)) for the quarter.
‘‘(2) PHASE-OUT PROPORTION.—For purposes
of paragraph (1)(C), the ‘phase-out proportion’ for
a calendar quarter in—
‘‘(A) 2003 is 80 percent;
‘‘(B) 2004 is 60 percent;
‘‘(C) 2005 is 40 percent;
‘‘(D) 2006 is 20 percent; or
‘‘(E) a year after 2006 is 0 percent.’’.
(c) MEDICAID PROVIDING WRAP-AROUND BENE-
FITS.—Section 1935 of such Act, as so inserted and
amended, is further amended by adding at the end the
following new subsection:
‘‘(d) ADDITIONAL PROVISIONS.—
‘‘(1) MEDICAID AS SECONDARY PAYOR.—In the
case of an individual dually entitled to qualified pre-
scription drug coverage under a prescription drug
plan under part D of title XVIII (or under a
Medicare+Choice plan under part C of such title)
and medical assistance for prescribed drugs under
this title, medical assistance shall continue to be pro-
vided under this title for prescribed drugs to the ex-
tent payment is not made under the prescription
drug plan or the Medicare+Choice plan selected by
the individual.
‘‘(2) CONDITION.—A State may require, as a
condition for the receipt of medical assistance under
this title with respect to prescription drug benefits
for an individual eligible to obtain qualified prescrip-
tion drug coverage described in paragraph (1), that
the individual elect qualified prescription drug cov-
erage under section 1860A.’’.
(d) TREATMENT OF TERRITORIES.—
(1) IN GENERAL.—Section 1935 of such Act, as
so inserted and amended, is further amended—
(A) in subsection (a)(1), by inserting ‘‘sub-
ject to subsection (e),’’ after ‘‘section 1903 ’’;
(B) in subsection (c)(1), by inserting ‘‘sub-
ject to subsection (e),’’ after ‘‘1903(a)’’; and
(C) by adding at the end the following new
subsection:
‘‘(e) TREATMENT OF TERRITORIES.—
‘‘(1) IN
GENERAL.—In the case of a State,
other than the 50 States and the District of
Columbia—
‘‘(A) the previous provisions of this section
shall not apply to residents of such State; and
‘‘(B) if the State establishes a plan de-
scribed in paragraph (2) (for providing medical
assistance with respect to the provision of pre-
scription drugs to medicare beneficiaries), the
amount otherwise determined under section
1108(f) (as increased under section 1108(g))
for the State shall be increased by the amount
specified in paragraph (3).
‘‘(2) PLAN.—The plan described in this para-
graph is a plan that—
‘‘(A) provides medical assistance with re-
spect to the provision of covered outpatient
drugs (as defined in section 1860B(f)) to low-
income medicare beneficiaries; and
‘‘(B) assures that additional amounts re-
ceived by the State that are attributable to the
operation of this subsection are used only for
such assistance.
‘‘(3) INCREASED AMOUNT.—
‘‘(A) IN GENERAL.—The amount specified
in this paragraph for a State for a year is equal
to the product of—
‘‘(i) the aggregate amount specified in
subparagraph (B); and
‘‘(ii) the amount specified in section
1108(g)(1) for that State, divided by the
sum of the amounts specified in such sec-
tion for all such States.
‘‘(B) AGGREGATE
AMOUNT.—The aggre-
gate amount specified in this subparagraph
for—
‘‘(i) 2003, is equal to $20,000,000; or
‘‘(ii) a subsequent year, is equal to the
aggregate amount specified in this sub-
paragraph for the previous year increased
by annual percentage increase specified in
section 1860(b)(5) for the year involved.
‘‘(4) REPORT.—The Secretary shall submit to
Congress a report on the application of this sub-
section and may include in the report such rec-
ommendations as the Secretary deems appropriate.’’.
(2) 
CONFORMING
AMENDMENT.—Section
1108(f) of such Act is amended by inserting ‘‘and
section 1935(e)(1)(B)’’ after ‘‘Subject to subsection
(g)’’.
SEC. 104. MEDIGAP TRANSITION PROVISIONS.
(a) IN GENERAL.—Notwithstanding any other provi-
sion of law, no new medicare supplemental policy that pro-
vides coverage of expenses for prescription drugs may be
issued under section 1882 of the Social Security Act on
or after January 1, 2003, to an individual unless it re-
places a medicare supplemental policy that was issued to
that individual and that provided some coverage of ex-
penses for prescription drugs.
(b) ISSUANCE OF SUBSTITUTE POLICIES IF OBTAIN
PRESCRIPTION DRUG COVERAGE THROUGH MEDICARE.—
(1) IN
GENERAL.—The issuer of a medicare
supplemental policy—
(A) may not deny or condition the issuance
or effectiveness of a medicare supplemental pol-
icy that has a benefit package classified as ‘‘A’’,
‘‘B’’, ‘‘C’’, ‘‘D’’, ‘‘E’’, ‘‘F’’, or ‘‘G’’ (under the
standards established under subsection (p)(2) of
section 1882 of the Social Security Act, 42
U.S.C. 1395ss) and that is offered and is avail-
able for issuance to new enrollees by such
issuer;
(B) may not discriminate in the pricing of
such policy, because of health status, claims ex-
perience, receipt of health care, or medical con-
dition; and
(C) may not impose an exclusion of bene-
fits based on a pre-existing condition under
such policy,
in the case of an individual described in paragraph
(2) who seeks to enroll under the policy not later
than 63 days after the date of the termination of en-
rollment described in such paragraph and who sub-
mits evidence of the date of termination or
disenrollment along with the application for such
medicare supplemental policy.
(2) INDIVIDUAL COVERED.—An individual de-
scribed in this paragraph is an individual who—
(A) enrolls in a prescription drug plan
under part D of title XVIII of the Social Secu-
rity Act; and
(B) at the time of such enrollment was en-
rolled and terminates enrollment in a medicare
supplemental policy which has a benefit pack-
age classified as ‘‘H’’, ‘‘I’’, or ‘‘J’’ under the
standards referred to in paragraph (1)(A) or
terminates enrollment in a policy to which such
standards do not apply but which provides ben-
efits for prescription drugs.
(3) ENFORCEMENT.—The provisions of para-
graph (1) shall be enforced as though they were in-
cluded in section 1882(s) of the Social Security Act
(42 U.S.C. 1395ss(s)).
(4) DEFINITIONS.—For purposes of this sub-
section, the term ‘‘medicare supplemental policy’’
has the meaning given such term in section 1882(g)
of the Social Security Act (42 U.S.C. 1395ss(g)).
TITLE II—MODERNIZATION OF
ADMINISTRATION OF MEDICARE
Subtitle A—Medicare Benefits
Administration
SEC. 201. ESTABLISHMENT OF ADMINISTRATION.
(a) IN GENERAL.—Title XVIII of the Social Security
Act (42 U.S.C. 1395 et seq.) is amended by inserting after
section 1806 the following new section:
‘‘MEDICARE BENEFITS ADMINISTRATION
‘‘SEC. 1807. (a) ESTABLISHMENT.—There is estab-
lished within the Department of Health and Human Serv-
ices an agency to be known as the Medicare Benefits Ad-
ministration.
‘‘(b) 
ADMINISTRATOR
AND
DEPUTY
ADMINIS-
TRATOR.—
‘‘(1) ADMINISTRATOR.—
‘‘(A) IN GENERAL.—The Medicare Bene-
fits Administration shall be headed by an Ad-
ministrator (in this section referred to as the
‘Administrator’) who shall be appointed by the
President, by and with the advice and consent
of the Senate. The Administrator shall be in di-
rect line of authority to the Secretary.
‘‘(B) COMPENSATION.—The Administrator
shall be paid at the rate of basic pay payable
for level III of the Executive Schedule under
section 5314 of title 5, United States Code.
‘‘(C) TERM
OF
OFFICE.—The Adminis-
trator shall be appointed for a term of 5 years.
In any case in which a successor does not take
office at the end of an Administrator’s term of
office, that Administrator may continue in of-
fice until the entry upon office of such a suc-
cessor. An Administrator appointed to a term of
office after the commencement of such term
may serve under such appointment only for the
remainder of such term.
‘‘(D) GENERAL AUTHORITY.—The Admin-
istrator shall be responsible for the exercise of
all powers and the discharge of all duties of the
Administration, and shall have authority and
control over all personnel and activities thereof.
‘‘(E) RULEMAKING AUTHORITY.—The Ad-
ministrator may prescribe such rules and regu-
lations as the Administrator determines nec-
essary or appropriate to carry out the functions
of the Administration. The regulations pre-
scribed by the Administrator shall be subject to
the rulemaking procedures established under
section 553 of title 5, United States Code.
‘‘(F) AUTHORITY TO ESTABLISH ORGANI-
ZATIONAL UNITS.—The Administrator may es-
tablish, alter, consolidate, or discontinue such
organizational units or components within the
Administration as the Administrator considers
necessary or appropriate, except that this sub-
paragraph shall not apply with respect to any
unit, component, or provision provided for by
this section.
‘‘(G) AUTHORITY TO DELEGATE.—The Ad-
ministrator may assign duties, and delegate, or
authorize successive redelegations of, authority
to act and to render decisions, to such officers
and employees of the Administration as the Ad-
ministrator may find necessary. Within the lim-
itations of such delegations, redelegations, or
assignments, all official acts and decisions of
such officers and employees shall have the same
force and effect as though performed or ren-
dered by the Administrator.
‘‘(2) DEPUTY ADMINISTRATOR.—
‘‘(A) IN GENERAL.—There shall be a Dep-
uty Administrator of the Medicare Benefits Ad-
ministration who shall be appointed by the
President, by and with the advice and consent
of the Senate.
‘‘(B) COMPENSATION.—The Deputy Ad-
ministrator shall be paid at the rate of basic
pay payable for level IV of the Executive Sched-
ule under section 5315 of title 5, United States
Code.
‘‘(C) TERM OF OFFICE.—The Deputy Ad-
ministrator shall be appointed for a term of 5
years. In any case in which a successor does not
take office at the end of a Deputy Administra-
tor’s term of office, such Deputy Administrator
may continue in office until the entry upon of-
fice of such a successor. A Deputy Adminis-
trator appointed to a term of office after the
commencement of such term may serve under
such appointment only for the remainder of
such term.
‘‘(D) DUTIES.—The Deputy Administrator
shall perform such duties and exercise such
powers as the Administrator shall from time to
time assign or delegate. The Deputy Adminis-
trator shall be Acting Administrator of the Ad-
ministration during the absence or disability of
the Administrator and, unless the President
designates another officer of the Government as
Acting Administrator, in the event of a vacancy
in the office of the Administrator.
‘‘(3) SECRETARIAL COORDINATION OF PROGRAM
ADMINISTRATION.—The Secretary shall ensure ap-
propriate coordination between the Administrator
and the Administrator of the Health Care Financing
Administration in carrying out the programs under
this title.
‘‘(c) DUTIES; ADMINISTRATIVE PROVISIONS.—
‘‘(1) DUTIES.—
‘‘(A) GENERAL
DUTIES.—The Adminis-
trator shall carry out parts C and D,
including—
‘‘(i) negotiating, entering into, and en-
forcing, contracts with plans for the offer-
ing of Medicare+Choice plans under part
C, including the offering of qualified pre-
scription drug coverage under such plans;
and
‘‘(ii) negotiating, entering into, and
enforcing, contracts with PDP sponsors for
the offering of prescription drug plans
under part D.
‘‘(B) OTHER DUTIES.—The Administrator
shall carry out any duty provided for under
part C or part D, including demonstration
projects carried out in part or in whole under
such parts, the programs of all-inclusive care
for the elderly (PACE program) under section
1894, the social health maintenance organiza-
tion (SHMO) demonstration projects (referred
to in section 4104(c) of the Balanced Budget
Act of 1997), and through a Medicare+Choice
project that demonstrates the application of
capitation payment rates for frail elderly medi-
care beneficiaries through the use of a inter-
disciplinary team and through the provision of
primary care services to such beneficiaries by
means of such a team at the nursing facility in-
volved).
‘‘(C) ANNUAL REPORTS.—Not later March
31 of each year, the Administrator shall submit
to Congress and the President a report on the
administration of parts C and D during the
previous fiscal year.
‘‘(2) STAFF.—
‘‘(A) IN
GENERAL.—The Administrator,
with the approval of the Secretary, may employ,
without regard to chapter 31 of title 5, United
States Code, such officers and employees as are
necessary to administer the activities to be car-
ried out through the Medicare Benefits Admin-
istration.
‘‘(B) FLEXIBILITY
WITH
RESPECT
TO
CIVIL SERVICE LAWS.—
‘‘(i) IN GENERAL.—The staff of the
Medicare Benefits Administration shall be
appointed without regard to the provisions
of title 5, United States Code, governing
appointments in the competitive service,
and, subject to clause (ii), shall be paid
without regard to the provisions of chapter
51 and chapter 53 of such title (relating to
classification and schedule pay rates).
‘‘(ii) MAXIMUM
RATE.—In no case
may the rate of compensation determined
under clause (i) exceed the rate of basic
pay payable for level IV of the Executive
Schedule under section 5315 of title 5,
United States Code.
‘‘(3) REDELEGATION OF CERTAIN FUNCTIONS
OF
THE
HEALTH
CARE
FINANCING
ADMINISTRA-
TION.—
‘‘(A) IN
GENERAL.—The Secretary, the
Administrator, and the Administrator of the
Health Care Financing Administration shall es-
tablish an appropriate transition of responsi-
bility in order to redelegate the administration
of part C from the Secretary and the Adminis-
trator of the Health Care Financing Adminis-
tration to the Administrator as is appropriate
to carry out the purposes of this section.
‘‘(B) TRANSFER OF DATA AND INFORMA-
TION.—The Secretary shall ensure that the Ad-
ministrator of the Health Care Financing Ad-
ministration transfers to the Administrator of
the Medicare Benefits Administration such in-
formation and data in the possession of the Ad-
ministrator of the Health Care Financing Ad-
ministration as the Administrator of the Medi-
care Benefits Administration requires to carry
out the duties described in paragraph (1).
‘‘(C) CONSTRUCTION.—Insofar as a re-
sponsibility of the Secretary or the Adminis-
trator of the Health Care Financing Adminis-
tration is redelegated to the Administrator
under this section, any reference to the Sec-
retary or the Administrator of the Health Care
Financing Administration in this title or title
XI with respect to such responsibility is deemed
to be a reference to the Administrator.
‘‘(d) OFFICE OF BENEFICIARY ASSISTANCE.—
‘‘(1) ESTABLISHMENT.—The Secretary shall es-
tablish within the Medicare Benefits Administration
an Office of Beneficiary Assistance to carry out
functions relating to medicare beneficiaries under
this title, including making determinations of eligi-
bility of individuals for benefits under this title, pro-
viding for enrollment of medicare beneficiaries under
this title, and the functions described in paragraph
(2). The Office shall be separate operating division
within the Administration.
‘‘(2) DISSEMINATION
OF
INFORMATION
ON
BENEFITS AND APPEALS RIGHTS.—
‘‘(A) DISSEMINATION OF BENEFITS INFOR-
MATION.—The Office of Beneficiary Assistance
shall disseminate to medicare beneficiaries, by
mail, by posting on the Internet site of the
Medicare Benefits Administration and through
the toll-free telephone number provided for
under section 1804(b), information with respect
to the following:
‘‘(i) Benefits, and limitations on pay-
ment (including cost-sharing, stop-loss pro-
visions, and formulary restrictions) under
parts C and D.
‘‘(ii) Benefits, and limitations on pay-
ment under parts A and B, including in-
formation on medicare supplemental poli-
cies under section 1882.
Such information shall be presented in a man-
ner so that medicare beneficiaries may compare
benefits under parts A, B, D, and medicare
supplemental 
policies 
with 
benefits 
under
Medicare+Choice plans under part C.
‘‘(B) DISSEMINATION OF APPEALS RIGHTS
INFORMATION.—The Office of Beneficiary As-
sistance shall disseminate to medicare bene-
ficiaries in the manner provided under subpara-
graph (A) a description of procedural rights (in-
cluding grievance and appeals procedures) of
beneficiaries under the original medicare fee-
for-service program under parts A and B, the
Medicare+Choice program under part C, and
the Voluntary Prescription Drug Benefit Pro-
gram under part D.
‘‘(3) MEDICARE OMBUDSMAN.—
‘‘(A) IN GENERAL.—Within the Office of
Beneficiary Assistance, there shall be a Medi-
care Ombudsman, appointed by the Secretary
from among individuals with expertise and ex-
perience in the fields of health care and advo-
cacy, to carry out the duties described in sub-
paragraph (B).
‘‘(B) DUTIES.—The Medicare Ombudsman
shall—
‘‘(i) receive complaints, grievances,
and requests for information submitted by
a medicare beneficiary, with respect to any
aspect of the medicare program;
‘‘(ii) provide assistance with respect to
complaints, grievances, and requests re-
ferred to in clause (i), including—
‘‘(I) assistance in collecting rel-
evant information for such bene-
ficiaries, to seek an appeal of a deci-
sion or determination made by a fiscal
intermediary, 
carrier,
Medicare+Choice 
organization, 
a
PDP sponsor under part D, or the
Secretary; and
‘‘(II) assistance to such bene-
ficiaries with any problems arising
from 
disenrollment 
from 
a
Medicare+Choice plan under part C
or a prescription drug plan under part
D; and
‘‘(iii) submit annual reports to Con-
gress, the Secretary, and the Medicare Pol-
icy Advisory Board describing the activities
of the Office, and including such rec-
ommendations for improvement in the ad-
ministration of this title as the Ombuds-
man determines appropriate.
‘‘(C) COORDINATION
WITH
STATE
OM-
BUDSMAN PROGRAMS AND CONSUMER ORGANI-
ZATIONS.—The Medicare Ombudsman shall, to
the extent appropriate, coordinate with State
medical Ombudsman programs, and with State-
and community-based consumer organizations,
to—
‘‘(i) provide information about the
medicare program; and
‘‘(ii) conduct outreach to educate
medicare beneficiaries with respect to man-
ners in which problems under the medicare
program may be resolved or avoided.
‘‘(e) MEDICARE POLICY ADVISORY BOARD.—
‘‘(1) ESTABLISHMENT.—There is established
within the Medicare Benefits Administration the
Medicare Policy Advisory Board (in this section re-
ferred to the ‘Board’). The Board shall advise, con-
sult with, and make recommendations to the Admin-
istrator of the Medicare Benefits Administration
with respect to the administration of parts C and D,
including the review of payment policies under such
parts.
‘‘(2) REPORTS.—
‘‘(A) IN GENERAL.—With respect to mat-
ters of the administration of parts C and D, the
Board shall submit to Congress and to the Ad-
ministrator of the Medicare Benefits Adminis-
tration such reports as the Board determines
appropriate. Each such report may contain such
recommendations as the Board determines ap-
propriate 
for 
legislative 
or 
administrative
changes to improve the administration of such
parts, including the topics described in subpara-
graph (B). Each such report shall be published
in the Federal Register.
‘‘(B) TOPICS
DESCRIBED.—Reports re-
quired under subparagraph (A) may include the
following topics:
‘‘(i) FOSTERING COMPETITION.—Rec-
ommendations or proposals to increase
competition under parts C and D for serv-
ices furnished to medicare beneficiaries.
‘‘(ii) 
EDUCATION
AND
ENROLL-
MENT.—Recommendations for the im-
provement to efforts to provide medicare
beneficiaries information and education on
the program under this title, and specifi-
cally parts C and D, and the program for
enrollment under the title.
‘‘(iii) IMPLEMENTATION OF RISK-AD-
JUSTMENT.—Evaluation of the implemen-
tation under section 1853(a)(3)(C) of the
risk adjustment methodology to payment
rates 
under 
that 
section 
to
Medicare+Choice organizations offering
Medicare+Choice plans that accounts for
variations in per capita costs based on
health status and other demographic fac-
tors.
‘‘(iv) DISEASE
MANAGEMENT
PRO-
GRAMS.—Recommendations on the incor-
poration of disease management programs
under parts C and D.
‘‘(C) MAINTAINING
INDEPENDENCE
OF
BOARD.—The Board shall directly submit to
Congress reports required under subparagraph
(A). No officer or agency of the United States
may require the Board to submit to any officer
or agency of the United States for approval,
comments, or review, prior to the submission to
Congress of such reports.
‘‘(3) DUTY OF ADMINISTRATOR OF MEDICARE
BENEFITS ADMINISTRATION.—With respect to any
report submitted by the Board under paragraph
(2)(A), not later than 90 days after the report is
submitted, the Administrator of the Medicare Bene-
fits Administration shall submit to Congress and the
President an analysis of recommendations made by
the Board in such report. Each such analysis shall
be published in the Federal Register.
‘‘(4) MEMBERSHIP.—
‘‘(A) APPOINTMENT.—Subject to the suc-
ceeding provisions of this paragraph, the Board
shall consist of 7 members to be appointed as
follows:
‘‘(i) 3 members shall be appointed by
the President.
‘‘(ii) 2 members shall be appointed by
the Speaker of the House of Representa-
tives, with the advice of the chairman and
the ranking minority member of the Com-
mittees on Ways and Means and on Com-
merce of the House of Representatives.
‘‘(iii) 2 members shall be appointed by
the President pro tempore of the Senate
with the advice of the chairman and the
ranking minority member of the Senate
Committee on Finance.
‘‘(B) 
QUALIFICATIONS.—The 
members
shall be chosen on the basis of their integrity,
impartiality, and good judgment, and shall be
individuals who are, by reason of their edu-
cation and experience in health care benefits
management, exceptionally qualified to perform
the duties of members of the Board.
‘‘(C) PROHIBITION ON INCLUSION OF FED-
ERAL EMPLOYEES.—No officer or employee of
the United States may serve as a member of
the Board.
‘‘(5) COMPENSATION.—Members of the Board
shall receive, for each day (including travel time)
they are engaged in the performance of the functions
of the board, compensation at rates not to exceed
the daily equivalent to the annual rate in effect for
level IV of the Executive Schedule under section
5315 of title 5, United States Code.
‘‘(6) TERMS OF OFFICE.—
‘‘(A) IN GENERAL.—The term of office of
members of the Board shall be 3 years.
‘‘(B) TERMS OF INITIAL APPOINTEES.—As
designated by the President at the time of ap-
pointment, of the members first appointed—
‘‘(i) 1 shall be appointed for a term of
1 year;
‘‘(ii) 3 shall be appointed for terms of
2 years; and
‘‘(iii) 3 shall be appointed for terms of
3 years.
‘‘(C) REAPPOINTMENTS.—Any person ap-
pointed as a member of the Board may not
serve for more than 8 years.
‘‘(D) VACANCY.—Any member appointed
to fill a vacancy occurring before the expiration
of the term for which the member’s predecessor
was appointed shall be appointed only for the
remainder of that term. A member may serve
after the expiration of that member’s term until
a successor has taken office. A vacancy in the
Board shall be filled in the manner in which the
original appointment was made.
‘‘(7) CHAIR.—The Chair of the Board shall be
elected by the members. The term of office of the
Chair shall be 3 years.
‘‘(8) MEETINGS.—The Board shall meet at the
call of the Chair, but in no event less than 3 times
during each fiscal year.
‘‘(9) DIRECTOR AND STAFF.—
‘‘(A) APPOINTMENT
OF
DIRECTOR.—The
Board shall have a Director who shall be ap-
pointed by the Chair.
‘‘(B) STAFF.—With the approval of the
Board, the Director may appoint and fix the
pay of such additional personnel as the Director
considers appropriate.
‘‘(C) FLEXIBILITY
IN
APPLICATION
OF
CIVIL SERVICE LAWS.—
‘‘(i) IN GENERAL.—The Director and
staff of the Board shall be appointed with-
out regard to the provisions of chapter 31
of title 5, United States Code, governing
appointments in the competitive service,
and, subject to clause (ii), shall be paid
without regard to the provisions of chap-
ters 51 and 53 of such title (relating to
classification and General Schedule pay
rates).
‘‘(ii) MAXIMUM
RATE.—In no case
may the rate of compensation determined
100
under clause (i) exceed the rate of basic
pay payable for level IV of the Executive
Schedule under section 5315 of title 5,
United States Code.
‘‘(D) ASSISTANCE
FROM
THE
ADMINIS-
TRATOR OF THE MEDICARE BENEFITS ADMINIS-
TRATION.—The Administrator of the Medicare
Benefits Administration shall make available to
the Board such information and other assist-
ance as it may require to carry out its func-
tions.
‘‘(10) CONTRACT AUTHORITY.—The Board may
contract with and compensate government and pri-
vate agencies or persons to carry out its duties
under this subsection, without regard to section
3709 of the Revised Statutes (41 U.S.C. 5).
‘‘(f) FUNDING.—There is authorized to be appro-
priated, in appropriate part from the Federal Hospital In-
surance Trust Fund and from the Federal Supplementary
Medical Insurance Trust Fund (including the Medicare
Prescription Drug Account), such sums as are necessary
to carry out this section.’’.
(b) EFFECTIVE DATE.—
101
(1) IN
GENERAL.—The amendment made by
subsection (a) shall take effect on the date of the en-
actment of this Act.
(2) TIMING OF INITIAL APPOINTMENTS.—The
Administrator and Deputy Administrator of the
Medicare Benefits Administration may not be ap-
pointed before March 1, 2001.
(3) DUTIES WITH RESPECT TO ELIGIBILITY DE-
TERMINATIONS
AND
ENROLLMENT.—The Adminis-
trator of the Medicare Benefits Administration shall
carry out enrollment under title XVIII of the Social
Security Act, make eligibility determinations under
such title, and carry out part C of such title for
years beginning or after January 1, 2003.
SEC. 202. MISCELLANEOUS ADMINISTRATIVE PROVISIONS.
(a) ADMINISTRATOR AS MEMBER OF THE BOARD OF
TRUSTEES OF THE MEDICARE TRUST FUNDS.—Section
1817(b) and section 1841(b) of the Social Security Act
(42 U.S.C. 1395i(b), 1395t(b)) are each amended by
striking ‘‘and the Secretary of Health and Human Serv-
ices, all ex officio,’’ and inserting ‘‘, the Secretary of
Health and Human Services, and the Administrator of the
Medicare Benefits Administration, all ex officio,’’.
102
(b) INCREASE IN GRADE TO EXECUTIVE LEVEL III
FOR THE ADMINISTRATOR OF THE HEALTH CARE FI-
NANCING ADMINISTRATION.—
(1) IN
GENERAL.—Section 5314 of title 5,
United States Code, by adding at the end the fol-
lowing:
‘‘Administrator of the Health Care Financing
Administration.’’.
(2) CONFORMING AMENDMENT.—Section 5315
of such title is amended by striking ‘‘Administrator
of the Health Care Financing Administration.’’.
(3) EFFECTIVE DATE.—The amendments made
by this subsection take effect on March 1, 2001.
Subtitle B—Oversight of Financial
Sustainability of the Medicare
Program
SEC. 211. ADDITIONAL REQUIREMENTS FOR ANNUAL FI-
NANCIAL REPORT AND OVERSIGHT ON MEDI-
CARE PROGRAM.
(a) IN GENERAL.—Section 1817 of the Social Secu-
rity Act (42 U.S.C. 1395i) is amended by adding at the
end the following new subsection:
‘‘(l) COMBINED REPORT ON OPERATION AND STATUS
OF
THE TRUST FUND
AND
THE FEDERAL SUPPLE-
MENTARY MEDICAL INSURANCE TRUST FUND.—
103
‘‘(1) IN GENERAL.—In addition to the duty of
the Board of Trustees to report to Congress under
subsection (b), on the date the Board submits the
report required under subsection (b)(2), the Board
shall submit to Congress a report on the operation
and status of the Trust Fund and the Federal Sup-
plementary Medical Insurance Trust Fund estab-
lished under section 1841 (in this subsection re-
ferred to as the ‘Trust Funds’). Such report shall
included the following information:
‘‘(A) OVERALL SPENDING FROM THE GEN-
ERAL FUND OF THE TREASURY.—A statement
of total amounts obligated during the preceding
fiscal year from the General Revenues of the
Treasury to the Trust Funds for payment for
benefits covered under this title, stated in terms
of the total amount and in terms of the per-
centage such amount bears to all other amounts
obligated from such General Revenues during
such fiscal year.
‘‘(B) HISTORICAL
OVERVIEW
OF
SPEND-
ING.—From the date of the inception of the
program of insurance under this title through
the fiscal year involved, a statement of the total
amounts referred to in subparagraph (A).
104
‘‘(C) 
10-YEAR
AND
50-YEAR
PROJEC-
TIONS.—An estimate of total amounts referred
to in subparagraph (A) required to be obligated
for payment for benefits covered under this title
for each of the 10 fiscal years succeeding the
fiscal year involved and for the 50-year period
beginning with the succeeding fiscal year.
‘‘(D) RELATION
TO
GDP
GROWTH.—A
comparison of the rate of growth of the total
amounts referred to in subparagraph (A) to the
rate of growth in the gross domestic product for
the same period.
‘‘(2) PUBLICATION.—Each report submitted
under paragraph (1) shall be published by the Com-
mittee on Ways and Means as a public document
and shall be made available by such Committee on
the Internet.’’.
(b) EFFECTIVE DATE.—The amendment made by
subsection (a) shall apply with respect to fiscal years be-
ginning on or after the date of the enactment of this Act.
(c) CONGRESSIONAL HEARINGS.—It is the sense of
Congress that the committees of jurisdiction shall hold
hearings on the reports submitted under section 1817(l)
of the Social Security Act.
105
Subtitle C—Changes in Medicare
Coverage and Appeals Process
SEC. 221. REVISIONS TO MEDICARE APPEALS PROCESS.
(a) CONDUCT OF RECONSIDERATIONS OF DETER-
MINATIONS
BY INDEPENDENT CONTRACTORS.—Section
1869 of the Social Security Act (42 U.S.C. 1395ff) is
amended to read as follows:
‘‘DETERMINATIONS; APPEALS
‘‘SEC. 1869. (a) INITIAL DETERMINATIONS.—The
Secretary shall promulgate regulations and make initial
determinations with respect to benefits under part A or
part B in accordance with those regulations for the fol-
lowing:
‘‘(1) The initial determination of whether an in-
dividual is entitled to benefits under such parts.
‘‘(2) The initial determination of the amount of
benefits available to the individual under such parts.
‘‘(3) Any other initial determination with re-
spect to a claim for benefits under such parts, in-
cluding an initial determination by the Secretary
that payment may not be made, or may no longer
be made, for an item or service under such parts, an
initial determination made by a utilization and qual-
ity control peer review organization under section
1154(a)(2), and an initial determination made by an
106
entity pursuant to a contract with the Secretary to
administer provisions of this title or title XI.
‘‘(b) APPEAL RIGHTS.—
‘‘(1) IN GENERAL.—
‘‘(A) RECONSIDERATION
OF
INITIAL
DE-
TERMINATION.—Subject to subparagraph (D),
any individual dissatisfied with any initial de-
termination under subsection (a) shall be enti-
tled to reconsideration of the determination,
and, subject to subparagraphs (D) and (E), a
hearing thereon by the Secretary to the same
extent as is provided in section 205(b) and to
judicial review of the Secretary’s final decision
after such hearing as is provided in section
205(g).
‘‘(B) REPRESENTATION BY PROVIDER OR
SUPPLIER.—
‘‘(i) IN
GENERAL.—Sections 206(a),
1102, and 1871 shall not be construed as
authorizing the Secretary to prohibit an in-
dividual from being represented under this
section by a person that furnishes or sup-
plies the individual, directly or indirectly,
with services or items, solely on the basis
107
that the person furnishes or supplies the
individual with such a service or item.
‘‘(ii) MANDATORY WAIVER OF RIGHT
TO
PAYMENT
FROM
BENEFICIARY.—Any
person that furnishes services or items to
an individual may not represent an indi-
vidual under this section with respect to
the issue described in section 1879(a)(2)
unless the person has waived any rights for
payment from the beneficiary with respect
to the services or items involved in the ap-
peal.
‘‘(iii) PROHIBITION ON PAYMENT FOR
REPRESENTATION.—If a person furnishes
services or items to an individual and rep-
resents the individual under this section,
the person may not impose any financial li-
ability on such individual in connection
with such representation.
‘‘(iv) 
REQUIREMENTS
FOR
REP-
RESENTATIVES OF A BENEFICIARY.—The
provisions of section 205(j) and section
206 (regarding representation of claim-
ants) shall apply to representation of an
individual with respect to appeals under
108
this section in the same manner as they
apply to representation of an individual
under those sections.
‘‘(C) SUCCESSION OF RIGHTS IN CASES OF
ASSIGNMENT.—The right of an individual to an
appeal under this section with respect to an
item or service may be assigned to the provider
of services or supplier of the item or service
upon the written consent of such individual
using a standard form established by the Sec-
retary for such an assignment.
‘‘(D) TIME LIMITS FOR APPEALS.—
‘‘(i) RECONSIDERATIONS.—Reconsid-
eration under subparagraph (A) shall be
available only if the individual described
subparagraph (A) files notice with the Sec-
retary to request reconsideration by not
later than 180 days after the individual re-
ceives notice of the initial determination
under subsection (a) or within such addi-
tional time as the Secretary may allow.
‘‘(ii) HEARINGS CONDUCTED BY THE
SECRETARY.—The Secretary shall establish
in regulations time limits for the filing of
a request for a hearing by the Secretary in
109
accordance with provisions in sections 205
and 206.
‘‘(E) AMOUNTS IN CONTROVERSY.—
‘‘(i) IN GENERAL.—A hearing (by the
Secretary) shall not be available to an indi-
vidual under this section if the amount in
controversy is less than $100, and judicial
review shall not be available to the indi-
vidual if the amount in controversy is less
than $1,000.
‘‘(ii) AGGREGATION
OF
CLAIMS.—In
determining the amount in controversy, the
Secretary, under regulations, shall allow 2
or more appeals to be aggregated if the ap-
peals involve—
‘‘(I) the delivery of similar or re-
lated services to the same individual
by one or more providers of services
or suppliers, or
‘‘(II) common issues of law and
fact arising from services furnished to
2 or more individuals by one or more
providers of services or suppliers.
‘‘(F) EXPEDITED PROCEEDINGS.—
110
‘‘(i) EXPEDITED
DETERMINATION.—
In the case of an individual who—
‘‘(I) has received notice by a pro-
vider of services that the provider of
services plans to terminate services
provided to an individual and a physi-
cian certifies that failure to continue
the provision of such services is likely
to place the individual’s health at sig-
nificant risk, or
‘‘(II) has received notice by a
provider of services that the provider
of services plans to discharge the indi-
vidual from the provider of services,
the individual may request, in writing or
orally, an expedited determination or an
expedited reconsideration of an initial de-
termination made under subsection (a), as
the case may be, and the Secretary shall
provide such expedited determination or
expedited reconsideration.
‘‘(ii) EXPEDITED
HEARING.—In a
hearing by the Secretary under this sec-
tion, in which the moving party alleges
that no material issues of fact are in dis-
111
pute, the Secretary shall make an expe-
dited determination as to whether any such
facts are in dispute and, if not, shall
render a decision expeditiously.
‘‘(G) REOPENING AND REVISION OF DE-
TERMINATIONS.—The Secretary may reopen or
revise any initial determination or reconsidered
determination described in this subsection
under guidelines established by the Secretary in
regulations.
‘‘(2) 
REVIEW
OF
COVERAGE
DETERMINA-
TIONS.—
‘‘(A) NATIONAL
COVERAGE
DETERMINA-
TIONS.—
‘‘(i) IN GENERAL.—Review of any na-
tional coverage determination shall be sub-
ject to the following limitations:
‘‘(I) Such a determination shall
not be reviewed by any administrative
law judge.
‘‘(II) Such a determination shall
not be held unlawful or set aside on
the ground that a requirement of sec-
tion 553 of title 5, United States
Code, or section 1871(b) of this title,
112
relating to publication in the Federal
Register or opportunity for public
comment, was not satisfied.
‘‘(III) Upon the filing of a com-
plaint by an aggrieved party, such a
determination shall be reviewed by the
Departmental Appeals Board of the
Department of Health and Human
Services. In conducting such a review,
the Departmental Appeals Board shall
review the record and shall permit dis-
covery and the taking of evidence to
evaluate the reasonableness of the de-
termination. In reviewing such a de-
termination, the Departmental Ap-
peals Board shall defer only to the
reasonable findings of fact, reasonable
interpretations of law, and reasonable
applications of fact to law by the Sec-
retary.
‘‘(IV) A decision of the Depart-
mental Appeals Board constitutes a
final agency action and is subject to
judicial review.
114
tations of law, and reasonable applications of
fact to law by the Secretary.
‘‘(ii) Such a determination may be re-
viewed by the Departmental Appeals Board of
the Department of Health and Human Services.
‘‘(iii) A decision of the Departmental Ap-
peals Board constitutes a final agency action
and is subject to judicial review.
‘‘(C) NO MATERIAL ISSUES OF FACT IN DIS-
PUTE.—In the case of review of a determination
under subparagraph (A)(i)(III) or (B)(i) where the
moving party alleges that there are no material
issues of fact in dispute, and alleges that the only
issue is the constitutionality of a provision of this
title, or that a regulation, determination, or ruling
by the Secretary is invalid, the moving party may
seek review by a court of competent jurisdiction.
‘‘(D) PENDING
NATIONAL
COVERAGE
DETER-
MINATIONS.—
‘‘(i) IN GENERAL.—In the event the Sec-
retary has not issued a national coverage or
noncoverage determination with respect to a
particular type or class of items or services, an
affected party may submit to the Secretary a
request to make such a determination with re-
115
spect to such items or services. By not later
than the end of the 90-day period beginning on
the date the Secretary receives such a request,
the Secretary shall take one of the following ac-
tions:
‘‘(I) Issue a national coverage deter-
mination, with or without limitations.
‘‘(II) Issue a national noncoverage de-
termination.
‘‘(III) Issue a determination that no
national coverage or noncoverage deter-
mination is appropriate as of the end of
such 90-day period with respect to national
coverage of such items or services.
‘‘(IV) Issue a notice that states that
the Secretary has not completed a review
of the national coverage determination and
that includes an identification of the re-
maining steps in the Secretary’s review
process and a deadline by which the Sec-
retary will complete the review and take an
action described in subclause (I), (II), or
(III).
‘‘(ii) In the case of an action described in
clause (i)(IV), if the Secretary fails to take an
116
action referred to in such clause by the deadline
specified by the Secretary under such clause,
then the Secretary is deemed to have taken an
action described in clause (i)(III) as of the
deadline.
‘‘(iii) When issuing a determination under
clause (i), the Secretary shall include an expla-
nation of the basis for the determination. An
action taken under clause (i) (other than sub-
clause (IV)) is deemed to be a national coverage
determination for purposes of review under sub-
paragraph (A).
‘‘(3) PUBLICATION ON THE INTERNET OF DECI-
SIONS OF HEARINGS OF THE SECRETARY.—Each de-
cision of a hearing by the Secretary shall be made
public, and the Secretary shall publish each decision
on the Medicare Internet site of the Department of
Health and Human Services. The Secretary shall re-
move from such decision any information that would
identify any individual, provider of services, or sup-
plier.
‘‘(4) LIMITATION ON REVIEW OF CERTAIN REG-
ULATIONS.—A regulation or instruction which re-
lates to a method for determining the amount of
payment under part B and which was initially issued
117
before January 1, 1981, shall not be subject to judi-
cial review.
‘‘(5) STANDING.—An action under this section
seeking review of a coverage determination (with re-
spect to items and services under this title) may be
initiated only by one (or more) of the following ag-
grieved persons, or classes of persons:
‘‘(A) Individuals entitled to benefits under
part A, or enrolled under part B, or both, who
are in need of the items or services involved in
the coverage determination.
‘‘(B) Persons, or classes of persons, who
make, manufacture, offer, supply, make avail-
able, or provide such items and services.
‘‘(c) CONDUCT
OF RECONSIDERATIONS
BY INDE-
PENDENT CONTRACTORS.—
‘‘(1) IN GENERAL.—The Secretary shall enter
into contracts with qualified independent contractors
to conduct reconsiderations of initial determinations
made under paragraphs (2) and (3) of subsection
(a). Contracts shall be for an initial term of three
years and shall be renewable on a triennial basis
thereafter.
‘‘(2) 
QUALIFIED
INDEPENDENT
CON-
TRACTOR.—For purposes of this subsection, the
118
term ‘qualified independent contractor’ means an en-
tity or organization that is independent of any orga-
nization under contract with the Secretary that
makes initial determinations under subsection (a),
and that meets the requirements established by the
Secretary consistent with paragraph (3).
‘‘(3) REQUIREMENTS.—Any 
qualified 
inde-
pendent contractor entering into a contract with the
Secretary under this subsection shall meet the fol-
lowing requirements:
‘‘(A) IN
GENERAL.—The qualified inde-
pendent contractor shall perform such duties
and functions and assume such responsibilities
as may be required under regulations of the
Secretary promulgated to carry out the provi-
sions of this subsection, and such additional du-
ties, functions, and responsibilities as provided
under the contract.
‘‘(B) 
DETERMINATIONS.—The 
qualified
independent contractor shall determine, on the
basis of such criteria, guidelines, and policies
established by the Secretary and published
under subsection (d)(2)(D), whether payment
shall be made for items or services under part
A or part B and the amount of such payment.
119
Such determination shall constitute the conclu-
sive determination on those issues for purposes
of payment under such parts for fiscal inter-
mediaries, carriers, and other entities whose de-
terminations are subject to review by the con-
tractor; except that payment may be made if—
‘‘(i) such payment is allowed by rea-
son of section 1879;
‘‘(ii) in the case of inpatient hospital
services or extended care services, the
qualified independent contractor deter-
mines that additional time is required in
order to arrange for postdischarge care,
but payment may be continued under this
clause for not more than 2 days, and only
in the case in which the provider of such
services did not know and could not rea-
sonably have been expected to know (as de-
termined under section 1879) that pay-
ment would not otherwise be made for
such services under part A or part B prior
to notification by the qualified independent
contractor under this subsection;
‘‘(iii) such determination is changed
as the result of any hearing by the Sec-
120
retary or judicial review of the decision
under this section; or
‘‘(iv) such payment is authorized
under section 1861(v)(1)(G).
‘‘(C) DEADLINES FOR DECISIONS.—
‘‘(i) DETERMINATIONS.—The quali-
fied independent contractor shall conduct
and conclude a determination under sub-
paragraph (B) or an appeal of an initial
determination, and mail the notice of the
decision by not later than the end of the
45-day period beginning on the date a re-
quest for reconsideration has been timely
filed.
‘‘(ii) CONSEQUENCES OF FAILURE TO
MEET DEADLINE.—In the case of a failure
by the qualified independent contractor to
mail the notice of the decision by the end
of the period described in clause (i), the
party requesting the reconsideration or ap-
peal may request a hearing before an ad-
ministrative law judge, notwithstanding
any requirements for a reconsidered deter-
mination for purposes of the party’s right
to such hearing.
121
‘‘(iii) 
EXPEDITED
RECONSIDER-
ATIONS.—The qualified independent con-
tractor shall perform an expedited recon-
sideration under subsection (b)(1)(F) of a
notice from a provider of services or sup-
plier that payment may not be made for an
item or service furnished by the provider of
services or supplier, of a decision by a pro-
vider of services to terminate services fur-
nished to an individual, or of a decision of
the provider of services to discharge the in-
dividual from the provider of services, in
accordance with the following:
‘‘(I) DEADLINE FOR DECISION.—
Notwithstanding section 216(j), not
later than 1 day after the date the
qualified independent contractor has
received a request for such reconsider-
ation and has received such medical
or other records needed for such re-
consideration, 
the 
qualified 
inde-
pendent contractor shall provide no-
tice (by telephone and in writing) to
the individual and the provider of
services and attending physician of
122
the individual of the results of the re-
consideration. Such reconsideration
shall be conducted regardless of
whether the provider of services or
supplier will charge the individual for
continued services or whether the indi-
vidual will be liable for payment for
such continued services.
‘‘(II) CONSULTATION WITH BEN-
EFICIARY.—In such reconsideration,
the qualified independent contractor
shall solicit the views of the individual
involved.
‘‘(D) LIMITATION ON INDIVIDUAL REVIEW-
ING DETERMINATIONS.—
‘‘(i) 
PHYSICIANS.—No 
physician
under the employ of a qualified inde-
pendent contractor may review—
‘‘(I) 
determinations 
regarding
health care services furnished to a pa-
tient if the physician was directly re-
sponsible for furnishing such services;
or
‘‘(II) determinations regarding
health care services provided in or by
123
an institution, organization, or agen-
cy, if the physician or any member of
the physician’s family has, directly or
indirectly, a significant financial inter-
est in such institution, organization,
or agency.
‘‘(ii) 
PHYSICIAN’S
FAMILY
DE-
SCRIBED.—For purposes of this para-
graph, a physician’s family includes the
physician’s spouse (other than a spouse
who is legally separated from the physician
under a decree of divorce or separate
maintenance), children (including step-
children and legally adopted children),
grandchildren, parents, and grandparents.
‘‘(E) 
EXPLANATION
OF
DETERMINA-
TIONS.—Any determination of a qualified inde-
pendent contractor shall be in writing, and shall
include a detailed explanation of the determina-
tion as well as a discussion of the pertinent
facts and applicable regulations applied in mak-
ing such determination.
‘‘(F) NOTICE REQUIREMENTS.—Whenever
a qualified independent contractor makes a de-
termination under this subsection, the qualified
124
independent contractor shall promptly notify
such individual and the entity responsible for
the payment of claims under part A or part B
of such determination.
‘‘(G) DISSEMINATION OF INFORMATION.—
Each qualified independent contractor shall,
using the methodology established by the Sec-
retary under subsection (d)(4), make available
all determinations of such qualified independent
contractors to fiscal intermediaries (under sec-
tion 1816), carriers (under section 1842), peer
review organizations (under part B of title XI),
Medicare+Choice 
organizations 
offering
Medicare+Choice plans under part C, and
other entities under contract with the Secretary
to make initial determinations under part A or
part B or title XI.
‘‘(H) ENSURING CONSISTENCY IN DETER-
MINATIONS.—Each qualified independent con-
tractor shall monitor its determinations to en-
sure consistency of determinations with respect
to requests for reconsideration of similar or re-
lated matters.
‘‘(I) DATA COLLECTION.—
125
‘‘(i) IN
GENERAL.—Consistent with
the requirements of clause (ii), a qualified
independent contractor shall collect such
information relevant to its functions, and
keep and maintain such records in such
form and manner as the Secretary may re-
quire to carry out the purposes of this sec-
tion and shall permit access to and use of
any such information and records as the
Secretary may require for such purposes.
‘‘(ii) TYPE
OF
DATA
COLLECTED.—
Each 
qualified 
independent 
contractor
shall keep accurate records of each deci-
sion made, consistent with standards es-
tablished by the Secretary for such pur-
pose. Such records shall be maintained in
an electronic database in a manner that
provides for identification of the following:
‘‘(I) Specific claims that give rise
to appeals.
‘‘(II) Situations suggesting the
need for increased education for pro-
viders of services, physicians, or sup-
pliers.
126
‘‘(III) Situations suggesting the
need for changes in national or local
coverage policy.
‘‘(IV) Situations suggesting the
need for changes in local medical re-
view policies.
‘‘(iii) 
ANNUAL
REPORTING.—Each
qualified independent contractor shall sub-
mit annually to the Secretary (or otherwise
as the Secretary may request) records
maintained under this paragraph for the
previous year.
‘‘(J) HEARINGS BY THE SECRETARY.—The
qualified independent contractor shall (i) pre-
pare such information as is required for an ap-
peal of its reconsidered determination to the
Secretary for a hearing, including as necessary,
explanations of issues involved in the deter-
mination and relevant policies, and (ii) partici-
pate in such hearings as required by the Sec-
retary.
‘‘(4) NUMBER
OF
QUALIFIED
INDEPENDENT
CONTRACTORS.—The Secretary shall enter into con-
tracts with not more than 12 qualified independent
contractors under this subsection.
127
‘‘(5) LIMITATION ON QUALIFIED INDEPENDENT
CONTRACTOR LIABILITY.—No qualified independent
contractor having a contract with the Secretary
under this subsection and no person who is em-
ployed by, or who has a fiduciary relationship with,
any such qualified independent contractor or who
furnishes professional services to such qualified inde-
pendent contractor, shall be held by reason of the
performance of any duty, function, or activity re-
quired or authorized pursuant to this subsection or
to a valid contract entered into under this sub-
section, to have violated any criminal law, or to be
civilly liable under any law of the United States or
of any State (or political subdivision thereof) pro-
vided due care was exercised in the performance of
such duty, function, or activity.
‘‘(d) ADMINISTRATIVE PROVISIONS.—
‘‘(1) OUTREACH.—The Secretary shall perform
such outreach activities as are necessary to inform
individuals entitled to benefits under this title and
providers of services and suppliers with respect to
their rights of, and the process for, appeals made
under this section. The Secretary shall use the toll-
free telephone number maintained by the Secretary
(1–800–MEDICAR(E)) (1–800–633–4227) to pro-
128
vide information regarding appeal rights and re-
spond to inquiries regarding the status of appeals.
‘‘(2) GUIDANCE FOR RECONSIDERATIONS AND
HEARINGS.—
‘‘(A) REGULATIONS.—Not later than 1
year after the date of the enactment of this sec-
tion, the Secretary shall promulgate regulations
governing the processes of reconsiderations of
determinations by the Secretary and qualified
independent contractors and of hearings by the
Secretary. Such regulations shall include such
specific criteria and provide such guidance as
required to ensure the adequate functioning of
the reconsiderations and hearings processes and
to ensure consistency in such processes.
‘‘(B) DEADLINES
FOR
ADMINISTRATIVE
ACTION.—
‘‘(i) HEARING
BY
ADMINISTRATIVE
LAW JUDGE.—
‘‘(II) IN
GENERAL.—Except as
provided in subclause (II), an admin-
istrative law judge shall conduct and
conclude a hearing on a decision of a
qualified 
independent 
contractor
under subsection (c) and render a de-
129
cision on such hearing by not later
than the end of the 90-day period be-
ginning on the date a request for
hearing has been timely filed.
‘‘(II) WAIVER OF DEADLINE BY
PARTY SEEKING HEARING.—The 90-
day period under subclause (i) shall
not apply in the case of a motion or
stipulation by the party requesting the
hearing to waive such period.
‘‘(ii) DEPARTMENTAL APPEALS BOARD
REVIEW.—The 
Departmental 
Appeals
Board of the Department of Health and
Human Services shall conduct and con-
clude a review of the decision on a hearing
described in subparagraph (B) and make a
decision or remand the case to the admin-
istrative law judge for reconsideration by
not later than the end of the 90-day period
beginning on the date a request for review
has been timely filed.
‘‘(iii) CONSEQUENCES OF FAILURE TO
MEET DEADLINES.—In the case of a fail-
ure by an administrative law judge to
render a decision by the end of the period
130
described in clause (ii), the party request-
ing the hearing may request a review by
the Departmental Appeals Board of the
Department of Health and Human Serv-
ices, notwithstanding any requirements for
a hearing for purposes of the party’s right
to such a review.
‘‘(iv) DAB HEARING PROCEDURE.—In
the case of a request described in clause
(iii), the Departmental Appeals Board
shall review the case de novo.
‘‘(C) POLICIES.—The Secretary shall pro-
vide such specific criteria and guidance, includ-
ing all applicable national and local coverage
policies and rationale for such policies, as is
necessary to assist the qualified independent
contractors to make informed decisions in con-
sidering appeals under this section. The Sec-
retary shall furnish to the qualified independent
contractors the criteria and guidance described
in this paragraph in a published format, which
may be an electronic format.
‘‘(D) PUBLICATION
OF
MEDICARE
COV-
ERAGE POLICIES ON THE INTERNET.—The Sec-
retary shall publish national and local coverage
131
policies under this title on an Internet site
maintained by the Secretary.
‘‘(E) EFFECT
OF
FAILURE
TO
PUBLISH
POLICIES.—
‘‘(i) NATIONAL AND LOCAL COVERAGE
POLICIES.—Qualified independent contrac-
tors shall not be bound by any national or
local medicare coverage policy established
by the Secretary that is not published on
the Internet site under subparagraph (D).
‘‘(ii) OTHER POLICIES.—With respect
to policies established by the Secretary
other than the policies described in clause
(i), qualified independent contractors shall
not be bound by such policies if the Sec-
retary does not furnish to the qualified
independent contractor the policies in a
published format consistent with subpara-
graph (C).
‘‘(3) CONTINUING
EDUCATION
REQUIREMENT
FOR QUALIFIED INDEPENDENT CONTRACTORS AND
ADMINISTRATIVE LAW JUDGES.—
‘‘(A) IN
GENERAL.—The Secretary shall
provide to each qualified independent con-
tractor, and to administrative law judges that
132
decide appeals of reconsiderations of initial de-
terminations or other decisions or determina-
tions under this section, such continuing edu-
cation with respect to policies of the Secretary
under this title or part B of title XI as is nec-
essary for such qualified independent contrac-
tors and administrative law judges to make in-
formed decisions with respect to appeals.
‘‘(B) MONITORING
OF
DECISIONS
BY
QUALIFIED INDEPENDENT CONTRACTORS AND
ADMINISTRATIVE LAW JUDGES.—The Secretary
shall monitor determinations made by all quali-
fied independent contractors and administrative
law judges under this section and shall provide
continuing education and training to such quali-
fied independent contractors and administrative
law judges to ensure consistency of determina-
tions with respect to appeals on similar or re-
lated matters. To ensure such consistency, the
Secretary shall provide for administration and
oversight of qualified independent contractors
and administrative law judges through a central
office of the Department of Health and Human
Services. Such administration and oversight
133
may not be delegated to regional offices of the
Department.
‘‘(4) DISSEMINATION
OF
DETERMINATIONS.—
The Secretary shall establish a methodology under
which qualified independent contractors shall carry
out subsection (c)(3)(G).
‘‘(5) SURVEY.—Not less frequently than every 5
years, the Secretary shall conduct a survey of a valid
sample of individuals entitled to benefits under this
title, providers of services, and suppliers to deter-
mine the satisfaction of such individuals or entities
with the process for appeals of determinations pro-
vided for under this section and education and train-
ing provided by the Secretary with respect to that
process. The Secretary shall submit to Congress a
report describing the results of the survey, and shall
include any recommendations for administrative or
legislative actions that the Secretary determines ap-
propriate.
‘‘(6) REPORT
TO
CONGRESS.—The Secretary
shall submit to Congress an annual report describing
the number of appeals for the previous year, identi-
fying issues that require administrative or legislative
actions, and including any recommendations of the
Secretary with respect to such actions. The Sec-
134
retary shall include in such report an analysis of de-
terminations by qualified independent contractors
with respect to inconsistent decisions and an anal-
ysis of the causes of any such inconsistencies.’’.
(b) APPLICABILITY OF REQUIREMENTS AND LIMITA-
TIONS ON LIABILITY OF QUALIFIED INDEPENDENT CON-
TRACTORS
TO MEDICARE+CHOICE INDEPENDENT AP-
PEALS CONTRACTORS.—Section 1852(g)(4) of the Social
Security Act (42 U.S.C. 1395w–22(e)(3)) is amended by
adding at the end the following: ‘‘The provisions of section
1869(c)(5) shall apply to independent outside entities
under contract with the Secretary under this paragraph.’’.
(c) CONFORMING AMENDMENT TO REVIEW BY THE
PROVIDER REIMBURSEMENT REVIEW BOARD.—Section
1878(g) of the Social Security Act (42 U.S.C. 1395oo(g))
is amended by adding at the end the following new para-
graph:
‘‘(3) Findings described in paragraph (1) and deter-
minations and other decisions described in paragraph (2)
may be reviewed or appealed under section 1869.’’.
SEC. 222. PROVISIONS WITH RESPECT TO LIMITATIONS ON
LIABILITY OF BENEFICIARIES.
(a) EXPANSION OF LIMITATION OF LIABILITY PRO-
TECTION FOR BENEFICIARIES WITH RESPECT TO MEDI-
CARE CLAIMS NOT PAID OR PAID INCORRECTLY.—
135
(1) IN GENERAL.—Section 1879 of the Social
Security Act (42 U.S.C. 1395pp) is amended by
adding at the end the following new subsections:
‘‘(i) Notwithstanding any other provision of this Act,
an individual who is entitled to benefits under this title
and is furnished a service or item is not liable for repay-
ment to the Secretary of amounts with respect to such
benefits—
‘‘(1) subject to paragraph (2), in the case of a
claim for such item or service that is incorrectly paid
by the Secretary; and
‘‘(2) in the case of payments made to the indi-
vidual by the Secretary with respect to any claim
under paragraph (1), the individual shall be liable
for repayment of such amount only up to the
amount of payment received by the individual from
the Secretary.
‘‘(j)(1) An individual who is entitled to benefits under
this title and is furnished a service or item is not liable
for payment of amounts with respect to such benefits in
the following cases:
‘‘(A) In the case of a benefit for which an ini-
tial determination has not been made by the Sec-
retary under subsection (a) whether payment may be
made under this title for such benefit.
136
‘‘(B) In the case of a claim for such item or
service that is—
‘‘(i) improperly submitted by the provider
of services or supplier; or
‘‘(ii) rejected by an entity under contract
with the Secretary to review or pay claims for
services and items furnished under this title, in-
cluding an entity under contract with the Sec-
retary under section 1857.
‘‘(2) The limitation on liability under paragraph (1)
shall not apply if the individual signs a waiver provided
by the Secretary under subsection (l) of protections under
this paragraph, except that any such waiver shall not
apply in the case of a denial of a claim for noncompliance
with applicable regulations or procedures under this title
or title XI.
‘‘(k) An individual who is entitled to benefits under
this title and is furnished services by a provider of services
is not liable for payment of amounts with respect to such
services prior to noon of the first working day after the
date the individual receives the notice of determination to
discharge and notice of appeal rights under paragraph (1),
unless the following conditions are met:
‘‘(1) The provider of services shall furnish a no-
tice of discharge and appeal rights established by the
138
guage inform such individuals of their limitations on liabil-
ity, their rights under section 1869(a) to obtain an initial
determination by the Secretary of whether payment may
be made under part A or part B for such benefit, and
their rights of appeal under section 1869(b), and shall in-
form such individuals that they may obtain further infor-
mation or file an appeal of the determination by use of
the toll-free telephone number (1–800–MEDICAR(E))
(1–800–633–4227) maintained by the Secretary. The
forms developed by the Secretary under this subsection
shall be the only manner in which such individuals may
waive such protections under this title or title XI.
‘‘(m) An individual who is entitled to benefits under
this title and is furnished an item or service is not liable
for payment of cost sharing amounts of more than $50
with respect to such benefits unless the individual has
been informed in advance of being furnished the item or
service of the estimated amount of the cost sharing for
the item or service using a standard form established by
the Secretary.’’.
(2) 
CONFORMING
AMENDMENT.—Section
1870(a) of the Social Security Act (42 U.S.C.
1395gg(a)) is amended by striking ‘‘Any payment
under this title’’ and inserting ‘‘Except as provided
in section 1879(i), any payment under this title’’.
139
(b) INCLUSION OF BENEFICIARY LIABILITY INFOR-
MATION IN EXPLANATION OF MEDICARE BENEFITS.—
Section 1806(a) of the Social Security Act (42 U.S.C.
1395b–7(a)) is amended—
(1) in paragraph (1), by striking ‘‘and’’ at the
end;
(2) by redesignating paragraph (2) as para-
graph (3); and
(3) by inserting after paragraph (1) the fol-
lowing new paragraph:
‘‘(2) lists with respect to each item or service
furnished the amount of the individual’s liability for
payment;’’;
(4) in paragraph (3), as so redesignated, by
striking the period at the end and inserting ‘‘; and’’;
and
(5) by adding at the end the following new
paragraph:
‘‘(4) includes the toll-free telephone number (1–
800–MEDICAR(E)) (1–800–633–4227) for infor-
mation and questions concerning the statement, li-
ability of the individual for payment, and appeal
rights.’’.
140
SEC. 223. WAIVERS OF LIABILITY FOR COST SHARING
AMOUNTS.
(a) IN GENERAL.—Section 1128A(i)(6)(A) of the So-
cial Security Act (42 U.S.C. 1320a–7a(i)(6)(A)) is amend-
ed by striking clauses (i) through (iii) and inserting the
following:
‘‘(i) the waiver is offered as a part of
a supplemental insurance policy or retiree
health plan;
‘‘(ii) the waiver is not offered as part
of any advertisement or solicitation, other
than in conjunction with a policy or plan
described in clause (i);
‘‘(iii) the person waives the coinsur-
ance and deductible amount after the bene-
ficiary informs the person that payment of
the coinsurance or deductible amount
would pose a financial hardship for the in-
dividual; or
‘‘(iv) the person determines that the
coinsurance and deductible amount would
not justify the costs of collection.’’.
(b) CONFORMING AMENDMENT.—Section 1128B(b)
of the Social Security Act (42 U.S.C. 1320a–7b(b)) is
amended by adding at the end the following new para-
graph:
141
‘‘(4) In this section, the term ‘remuneration’ in-
cludes the meaning given such term in section
1128A(i)(6).’’.
SEC. 224. ELIMINATION OF MOTIONS BY THE SECRETARY
ON DECISIONS OF THE PROVIDER REIM-
BURSEMENT REVIEW BOARD.
Section 
1878(f)(1) 
of 
such 
Act 
(42 
U.S.C.
1395oo(f)(1)) is amended—
(1) in the first sentence, by striking ‘‘unless the
Secretary, on his own motion, and within 60 days
after the provider of services is notified of the
Board’s decision, reverses, affirms, or modifies the
Board’s decision’’;
(2) in the second sentence, by striking ‘‘, or of
any reversal, affirmance, or modification by the Sec-
retary,’’ and ‘‘or of any reversal, affirmance, or
modification by the Secretary’’; and
(3) in the fifth sentence, by striking ‘‘ and not
subject to review by the Secretary’’.
142
TITLE 
III—MEDICARE+CHOICE
REFORMS; PRESERVATION OF
MEDICARE 
PART 
B 
DRUG
BENEFIT
Subtitle A—Medicare+Choice
Reforms
SEC. 
301. 
INCREASE 
IN 
NATIONAL 
PER 
CAPITA
MEDICARE+CHOICE GROWTH PERCENTAGE
IN 2001 AND 2002.
Section 1853(c)(6)(B) of the Social Security Act (42
U.S.C. 1395w–23(c)(6)(B)) is amended—
(1) in clause (iv), by striking ‘‘for 2001, 0.5
percentage points’’ and inserting ‘‘for 2001, 0.4 per-
centage points’’; and
(2) in clause (v), by striking ‘‘for 2002, 0.3 per-
centage points’’ and inserting ‘‘for 2002, 0.2 per-
centage points’’.
SEC. 302. PERMANENTLY REMOVING APPLICATION OF
BUDGET NEUTRALITY BEGINNING IN 2002.
Section 1853(c) of the Social Security Act (42 U.S.C.
1395w–23(c)) is amended—
(1) in paragraph (1)(A), in the matter following
clause (ii), by inserting ‘‘(for years before 2002)’’
after ‘‘multiplied’’; and
143
(2) in paragraph (5), by inserting ‘‘(before
2002)’’ after ‘‘for each year’’.
SEC. 303. INCREASING MINIMUM PAYMENT AMOUNT.
(a) IN GENERAL.—Section 1853(c)(1)(B)(ii) of the
Social Security Act (42 U.S.C. 1395w–23(c)(1)(B)(ii)) is
amended—
(1) by striking ‘‘(ii) For a succeeding year’’ and
inserting ‘‘(ii)(I) Subject to subclause (II), for a suc-
ceeding year’’; and
(2) by adding at the end the following new sub-
clause:
‘‘(II) For 2002 for any of the 50
States and the District of Columbia,
$450.’’.
(b) EFFECTIVE DATE.—The amendments made by
subsection (a) apply to years beginning with 2002.
SEC. 304. ALLOWING MOVEMENT TO 50:50 PERCENT BLEND
IN 2002.
Section 1853(c)(2) of the Social Security Act (42
U.S.C. 1395w–23(c)(2)) is amended—
(1) by striking the period at the end of sub-
paragraph (F) and inserting a semicolon; and
(2) by adding after and below subparagraph
(F) the following:
144
‘‘except that a Medicare+Choice organization may
elect to apply subparagraph (F) (rather than sub-
paragraph (E)) for 2002.’’.
SEC. 305. INCREASED UPDATE FOR PAYMENT AREAS WITH
ONLY ONE OR NO MEDICARE+CHOICE CON-
TRACTS.
(a) IN GENERAL.—Section 1853(c)(1)(C)(ii) of the
Social Security Act (42 U.S.C. 1395w–23(c)(1)(C)(ii)) is
amended—
(1) in clause (i), by striking ‘‘(ii) For a subse-
quent year’’ and inserting ‘‘(ii)(I) Subject to sub-
clause (II), for a subsequent year’’; and
(2) by adding at the end the following new sub-
clause:
‘‘(II) During 2002, 2003, 2004, and
2005, in the case of a Medicare+Choice
payment area in which there is no more
than 1 contract entered into under this
part as of July 1 before the beginning of
the year, 102.5 percent of the annual
Medicare+Choice capitation rate under
this paragraph for the area for the pre-
vious year.’’.
(b) CONSTRUCTION.—The amendments made by sub-
section (a) do not affect the payment of a first time bonus
145
under section 1853(i) of the Social Security Act (42
U.S.C. 1395w–23(i)).
SEC. 306. PERMITTING HIGHER NEGOTIATED RATES IN
CERTAIN 
MEDICARE+CHOICE 
PAYMENT
AREAS BELOW NATIONAL AVERAGE.
Section 1853(c)(1) of the Social Security Act (42
U.S.C. 1395w–23(c)(1)) is amended—
(1) in the matter before subparagraph (A), by
striking ‘‘or (C)’’ and inserting ‘‘(C), or (D)’’; and
(2) by adding at the end the following new sub-
paragraph:
‘‘(D) 
PERMITTING
HIGHER
RATES
THROUGH NEGOTIATION.—
‘‘(i) IN GENERAL.—For each year be-
ginning with 2004, in the case of a
Medicare+Choice payment area for which
the Medicare+Choice capitation rate under
this paragraph would otherwise be less
than the United States per capita cost
(USPCC), as calculated by the Secretary,
a Medicare+Choice organization may ne-
gotiate with the Medicare Benefits Admin-
istrator an annual per capita rate that—
146
‘‘(I) reflects an annual rate of in-
crease up to the rate of increase speci-
fied in clause (ii);
‘‘(II) takes into account audited
current data supplied by the organiza-
tion on its adjusted community rate
(as defined in section 1854(f)(3)); and
‘‘(III) does not exceed the United
States per capita cost, as projected by
the Secretary for the year involved.
‘‘(ii) MAXIMUM
RATE
DESCRIBED.—
The rate of increase specified in this clause
for a year is the rate of inflation in private
health insurance for the year involved, as
projected by the Medicare Benefits Admin-
istrator, and includes such adjustments as
may be necessary—
‘‘(I) to reflect the demographic
characteristics in the population under
this title; and
‘‘(II) to eliminate the costs of
prescription drugs.
‘‘(iii) ADJUSTMENTS
FOR
OVER
OR
UNDER PROJECTIONS.—If subparagraph is
applied to an organization and payment
147
area for a year, in applying this subpara-
graph for a subsequent year the provisions
of paragraph (6)(C) shall apply in the
same manner as such provisions apply
under this paragraph.’’.
SEC. 307. 10-YEAR PHASE IN OF RISK ADJUSTMENT BASED
ON DATA FROM ALL SETTINGS.
Section 1853(a)(3)(C)(ii) of the Social Security Act
(42 U.S.C. 1395w–23(c)(1)(C)(ii)) is amended—
(1) by striking the period at the end of sub-
clause (II) and inserting a semicolon; and
(2) by adding after and below subclause (II) the
following:
‘‘and, beginning in 2004, insofar as such
risk adjustment is based on data from all
settings, the methodology shall be phased
in equal increments over a 10 year period,
beginning with 2004 or (if later) the first
year in which such data is used.’’.
148
Subtitle B—Preservation of Medi-
care Coverage of Drugs and
Biologicals
SEC. 311. PRESERVATION OF COVERAGE OF DRUGS AND
BIOLOGICALS UNDER PART B OF THE MEDI-
CARE PROGRAM.
(a) IN GENERAL.—Section 1861(s)(2) of the Social
Security Act (42 U.S.C. 1395x(s)(2)) is amended, in each
of subparagraphs (A) and (B), by striking ‘‘(including
drugs and biologicals which cannot, as determined in ac-
cordance with regulations, be self-administered)’’ and in-
serting ‘‘(including drugs and biologicals which are not
usually self-administered by the patient)’’.
(b) EFFECTIVE DATE.—The amendment made by
subsection (a) applies to drugs and biologicals adminis-
tered on or after October 1, 2000.
Æ